Antigenic differentiation of classical swine fever viruses in China by monoclonal antibody
生物免疫学英文词汇学习---
医学免疫学英中文词汇Aaccessibility易接近性acetylcholine,Ach 乙酰胆碱acquired immune deficiency syndrome,AIDS获得性免疫缺陷综合征(艾滋病)acquired tolerance 获得性免疫耐受activation-induced cell death,AICD,活化诱导的细胞凋亡active immunotherapy主动免疫疗法acute phase protein,APP急性期蛋白acute rejection急性排斥反应acute vascular rejection,AVR急性血管性排斥adaptive immune system适应性免疫系统adaptive immunity 适应性免疫adenosine deaminase,ADA腺苷脱氨酶adhesion molecule,AM黏附分子adjuvant佐剂adoptive immunity过继免疫adult thymectomy,AT成年胸腺切除术affinity亲和力affinitymaturation(抗体)亲和力成熟agglutination凝集反应alkalinephosphatase,AP碱性磷酸酶allergen变应原allergicinflammation,AI变态反应炎症alloantigen同种异型抗原allograft同种异基因移植allotype同种异型alpha-fetoprotein,√廿P甲胎球蛋白alternative pathway旁路(替代)途径anaphylatoxin过敏毒素anaphylaxis过敏反应ankylosingspondylitis,AS强直性脊柱炎antibody dependentcell-mediatedcytotoxicity,ADCC抗体依赖性细胞介导的细胞毒作用antibody,Ab抗体,antigenpresentation抗原提呈antigen presentingcell,APC抗原提呈细胞,antigen,Ag抗原,antigen-bindingfragment,Fab抗原结合片段,antigen-binding site抗原结合部位,antigenicdeterminant,AD抗原决定簇antigenic valence抗原结合价,antigenicity抗原性,anti-idiotype,Aid抗独特型anti—infectionimmunity抗感染免疫antiserum抗血清antitoxin抗毒素apoptosis细胞凋亡artificial activeimmunization人工主动免疫artificial antigen人工抗原artificial passiveimmunization人工被动免疫ataxia telangiectasia,AT 毛细血管扩张性共济失调综合征atopy特应性attenuated vaccine减毒活疫苗autoantigen 自身抗原autograft 自体移植autoimmunedisease 自身免疫病autoimmunity自身免疫avidin亲和素(抗生物素蛋白)avidity亲合力azoprotein偶氮蛋白Bp barrel p桶状p lysin乙型溶素B cell receptor,BCR B细胞受体basophil嗜碱粒细胞Bence-Jones protem 本周蛋白bbfunction anibody,B{Ab双功能抗体Bioinformaties生物信息学biological response modifier,BRM 生物应答调节剂biotin生物素,biotin-avidin system,BAS生物素一亲和素系统bi-specific antibody,BsAb双特异抗体bone marrow骨髓bovine gamma globulin,BGG牛丙种球蛋白bradykinin缓激肽bursa of Fabricius法氏囊bursa or bonemarfow dependentlymphocyte法氏囊或骨髓依赖的淋巴细胞(B细胞)CC reaction protein,CRP C反应蛋白C1 inhibitor,C1INHC1抑制物C3b inactivator C3b灭活因子(I因子)CA binding protein,CAbp CA结合蛋白Cadherin钙黏蛋白Calnexin钙联蛋白carcinoembryonicantigen,CEA癌胚抗原carrier载体carrier effect载体效应Caspase半胱天冬蛋白酶CD40 ligand,CD40LCIM0配体cell surface marker细胞表面标记cellular rejection细胞性排斥反应central immuneorgan中枢免疫器官central tolerance中枢耐受centroblast生发中心母细胞chemokine趋化因子chemotaxis趋化性chimeric antibody嵌合抗体chronic rejection慢性排斥反应class 11-associatedinvariant chainpeptide,CLIP Ⅱ类相关的恒定链肽段classical pathway经典途径clonal anergy克隆无能clonal deletion克隆清除clonal selectiontheory克隆选择学说cluster ofdifferentiation,CD分化群codominance共显性collagen,CA胶原蛋白colony forming unit-culture,CFU-C体外培养集落形成单位colony forming unit-spleen,CFU-S 脾集落形成单位colony stimulatingfactor,CSF集落刺激因子committed stem cell定向干细胞common antigen共同抗原complementdependentcytotoxicity,CDC补体依赖的细胞毒complementreceptor,CR补体受体complement system补体系统complement,C补体complementaritydetermining region,CDR互补决定区complete antigen完全抗原concanavalin A,ConA刀豆蛋白Aconformational determinant构象决定簇conjugate vaccine结合疫苗constant region,C 区恒定区Coombs test抗球蛋白试验coreceptor共受体cortex皮质区co-stimulatory molecule receptor,CMR 协同刺激分子受体co-stimulatory molecule,CM协同刺激分子cross-reaction交叉反应crystallizable fragment,Fe可结晶片段CTL antigen-4,Cn。
《医学免疫学 》教学课件:第二章 抗原
二、抗原的特异性
抗原的特异性是指抗原刺激机体产生特异 性免疫应答及其与免疫应答产物(即相应 抗体和/或效应T细胞)相互作用的高度专一 性。
某一特定抗原只引起某种特定的免疫应答, 即产生针对该抗原的特异性抗体或效应T细胞。
破伤风类毒素(Ag) 机体 破伤风抗毒素(Ab)
白喉类毒素(Ag) 机体 白喉抗毒素(Ab)
国际命名机构将来自不同实验室的单克隆抗体所识别鉴定的同一分化抗原归为同一个分化是一类主要由细菌外毒素和某些病毒蛋白产物组成的抗原性物质此类抗原作用不受mhc限制无抗原特异性只需极低浓度即可激活多个淋巴细胞克隆产生极强免疫应答的抗原性物质
第二章 抗原
重点提示
基本概念 影响抗原免疫原性的因素 抗原的特异性 医学上重要的抗原物质
用右旋、左旋、消旋酒石酸三种异构体半抗原所做的实验证实,特殊 化学基团(表位)的立体构象出现微小差异也可使其免疫原性和抗原 性发生改变。
抗原表位的分类
按结构分为: 顺序表位(线性表位):是一段序列相连续 的氨基酸片段,多位于抗原分子内部,少 数位于抗原分子表面。 构象表位:是序列上不相连的多肽或多糖, 由空间构象形成,位于抗原分子表面。
免疫原性(immunogenicity):抗原能够刺激机体 产生抗体和/或效应T细胞的能力。
抗原性(antigenicity):抗原能与免疫应答产物即 相应抗体和/或效应T细胞特异性结合的能力,又 称免疫反应性。
抗原一般具备免疫原性与抗原性两种特性。免疫 原性指能刺激诱导机体产生免疫应答的能力,抗 原性指能与免疫应答产物特异性结合的能力。抗 原性是一个化学概念,免疫原性是一个生物学概 念。
遗传因素 年龄、性别和健康状态
免疫方法
抗原剂量:剂量应适中,过低和过高均易诱导机 体产生免疫耐受。
生物免疫学英文词汇汇总学习---
医学免疫学英中文词汇Aaccessibility易接近性acetylcholine,Ach 乙酰胆碱acquired immune deficiency syndrome,AIDS获得性免疫缺陷综合征(艾滋病)acquired tolerance 获得性免疫耐受activation-induced cell death,AICD,活化诱导的细胞凋亡active immunotherapy主动免疫疗法acute phase protein,APP急性期蛋白acute rejection急性排斥反应acute vascular rejection,AVR急性血管性排斥adaptive immune system适应性免疫系统adaptive immunity 适应性免疫adenosinedeaminase,ADA腺苷脱氨酶adhesionmolecule,AM黏附分子adjuvant佐剂adoptive immunity过继免疫adult thymectomy,AT成年胸腺切除术affinity亲和力affinitymaturation(抗体)亲和力成熟agglutination凝集反应alkalinephosphatase,AP碱性磷酸酶allergen变应原allergicinflammation,AI变态反应炎症alloantigen同种异型抗原allograft同种异基因移植allotype同种异型alpha-fetoprotein,√廿P甲胎球蛋白alternative pathway旁路(替代)途径anaphylatoxin过敏毒素anaphylaxis过敏反应ankylosingspondylitis,AS强直性脊柱炎antibody dependentcell-mediatedcytotoxicity,ADCC抗体依赖性细胞介导的细胞毒作用antibody,Ab抗体,antigenpresentation抗原提呈antigen presentingcell,APC抗原提呈细胞,antigen,Ag抗原,antigen-bindingfragment,Fab抗原结合片段,antigen-binding site抗原结合部位,antigenicdeterminant,AD抗原决定簇antigenic valence抗原结合价,antigenicity抗原性,anti-idiotype,Aid抗独特型anti—infectionimmunity抗感染免疫antiserum抗血清antitoxin抗毒素apoptosis细胞凋亡artificial activeimmunization人工主动免疫artificial antigen人工抗原artificial passiveimmunization人工被动免疫ataxiatelangiectasia,AT毛细血管扩张性共济失调综合征atopy特应性attenuated vaccine减毒活疫苗autoantigen 自身抗原autograft 自体移植autoimmunedisease 自身免疫病autoimmunity自身免疫avidin亲和素(抗生物素蛋白)avidity亲合力azoprotein偶氮蛋白Bp barrel p桶状p lysin乙型溶素B cell receptor,BCR B细胞受体basophil嗜碱粒细胞Bence-Jones protem 本周蛋白bbfunction anibody,B{Ab双功能抗体Bioinformaties生物信息学biological response modifier,BRM 生物应答调节剂biotin生物素, biotin-avidin system,BAS生物素一亲和素系统bi-specificantibody,BsAb双特异抗体bone marrow骨髓bovine gammaglobulin,BGG牛丙种球蛋白bradykinin缓激肽bursa of Fabricius法氏囊bursa or bonemarfow dependentlymphocyte法氏囊或骨髓依赖的淋巴细胞(B细胞)CC reaction protein,CRP C反应蛋白C1 inhibitor,C1INHC1抑制物C3b inactivator C3b灭活因子(I因子)CA binding protein,CAbp CA结合蛋白Cadherin钙黏蛋白Calnexin钙联蛋白carcinoembryonicantigen,CEA癌胚抗原carrier载体carrier effect载体效应Caspase半胱天冬蛋白酶CD40 ligand,CD40LCIM0配体cell surface marker细胞表面标记cellular rejection细胞性排斥反应central immuneorgan中枢免疫器官central tolerance中枢耐受centroblast生发中心母细胞chemokine趋化因子chemotaxis趋化性chimeric antibody嵌合抗体chronic rejection慢性排斥反应class 11-associatedinvariant chainpeptide,CLIP Ⅱ类相关的恒定链肽段classical pathway经典途径clonal anergy克隆无能clonal deletion克隆清除clonal selectiontheory克隆选择学说cluster ofdifferentiation,CD分化群codominance共显性collagen,CA胶原蛋白colony formingunit-culture,CFU-C体外培养集落形成单位colony formingunit-spleen,CFU-S脾集落形成单位colony stimulatingfactor,CSF集落刺激因子committed stem cell定向干细胞common antigen共同抗原complementdependentcytotoxicity,CDC补体依赖的细胞毒complementreceptor,CR补体受体complement system 补体系统complement,C补体complementarity determining region,CDR互补决定区complete antigen完全抗原concanavalin A,ConA刀豆蛋白Aconformational determinant构象决定簇conjugate vaccine结合疫苗constant region,C 区恒定区Coombs test抗球蛋白试验coreceptor共受体cortex皮质区co-stimulatory molecule receptor,CMR 协同刺激分子受体co-stimulatory molecule,CM协同刺激分子cross-reaction交叉反应crystallizablefragment,Fe可结晶片段CTL antigen-4,Cn。
医学免疫学名词解释 (2)
第一章免疫(immunity)机体识别与排除抗原性异物,维持机体正常生理平衡与稳定得功能.免疫防御(immune defense)防止外界病原体得入侵及清除已入侵病原体(如细菌、病毒、真菌、支原体、衣原体、寄生虫等)及其她有害物质。
免疫监视(immune surveillance)随时发现与清除体内出现得“非己”成分,如肿瘤细胞与衰老、凋亡细胞。
免疫自身稳定(immunehomeostasis)通过自身免疫耐受与免疫调节两种主要得机制来达到免疫系统内环境得稳定.免疫应答(immune response)就是指免疫系统识别与清除抗原得整个过程。
第二章造血诱导微环境(hemopoieticinductive microenvironment,HIM)由基质细胞及其所分泌得多种细胞因子(IL—3、IL—4、IL—6、IL—7、SCF、GM—CSF等)与细胞外基质共同构成得造血细胞赖以分化发育得环境。
脾集落形成单位(colony forming unit-spleen,CFU-S)应用同系小鼠骨髓细胞输注给经射线照射得小鼠,可在受体小鼠脾脏内形成由单一骨髓干细胞发育分化而来得细胞集落,包括红细胞、粒细胞与巨核细胞等,此称为脾集落形成单位。
体外培养集落形成单位(colony formingunit—culture,CFU—C)用半固体培养技术,在有造血生长因子存在得条件下,干细胞在体外可以分化为不同谱系得细胞集落,称为体外培养集落形成单位。
初始淋巴细胞(naïve lymphocyte)尚未接触过抗原得成熟B、T细胞被称为初始淋巴细胞。
淋巴细胞归巢(lymphocyte homing)成熟淋巴细胞离开中枢免疫器官后,经血液循环趋向性迁移并定居于外周免疫器官或组织得特定区域,称为淋巴细胞归巢。
淋巴细胞再循环(lymphocyterecirculation)淋巴细胞在血液、淋巴液、淋巴器官与组织间反复循环得过程称为淋巴细胞再循环.第三章抗原(antigen,Ag)就是指能与T细胞、B淋巴细胞得TCR或BCR结合,促使其增殖、分化,产生抗体或致敏淋巴细胞,并与之结合,进而发挥免疫效应得物质。
医学免疫名解
概论1.medical immunology医学免疫学:研究人体免疫系统的结构和功能的科学。
2.immune defense 免疫防御:体内免疫系统防止外界病原体入侵或清除已入侵病原体及其他有害物质的功能。
3.immune surveillance 免疫监视:体内免疫系统随时发现和清除体内出现的非几成分的功能。
4.immune homeostasis 免疫自身稳定:体内免疫系统通过自身免疫耐受和免疫调节两种主要机制来达到免疫系统内环境稳态的功能。
5.immune response 免疫应答:免疫系统识别和清除非己物质的整个过程。
6.immunity免疫:是指机体识别“自己”与“非己”抗原,对自身抗原形成天然免疫耐受,对非己抗原发生排斥作用的一种生理功能。
正常情况下,对机体有利;免疫功能失调时,会产生对机体有害的反应。
免疫器官和组织1.central immune organ 中枢免疫器官:是免疫细胞发生、分化、发育和成熟的场所。
人或其他哺乳类动物的中枢免疫器官包括骨髓和胸腺。
2.bone marrow 骨髓:各类血细胞的发源地,也是人和哺乳动物B细胞发育成熟的场所。
3.thymus 胸腺:T细胞分化、发育、成熟的场所。
4.peripheral immune organ 外周免疫器官:成熟淋巴细胞成熟的场所,也是各类淋巴细胞对外来抗原产生免疫应答的主要部位。
外周免疫器官和组织包括淋巴结、脾和粘膜相关淋巴组织等。
5.immune system 免疫系统:由免疫器官、免疫细胞和免疫分子组成,其功能是执行免疫功能。
抗原1.antigen,Ag 抗原:指所有能激活和诱导免疫应答的物质,通常指能被TB淋巴细胞表面特异性抗原受体(BCR OR TCR)识别并结合,激活TB细胞增殖分化产生免疫应答效应产物,并与效应产物结合,进而发挥适应性免疫应答效应的产物。
2.immunogenicity 免疫原性:抗原被TCR,BCR识别并结合,诱导机体产生适应性免疫应答的能力。
微生物基本术语
微生物基本术语abnormal excision 不正常切离acervulus 分生孢子盘acidophiles 嗜酸菌acidotolerant microorganism 耐酸微生物acquired specific immunity 获得特异性免疫activated acetic acid pathway 活性乙酸途径或厌氧乙酰辅酶A途径activated sludge 活性污泥actinomycetes 放线菌acute infection 急性感染adjuvant 佐剂,adsorption 吸附全称免疫佐剂aerial mycelium 气生菌丝aerobe 好氧菌aerotolerant anaerobe 耐氧菌agglutination reaction 凝集反应akinete 静息孢alkalophiles 嗜碱菌allergy 变态反应或过敏反应allotype 同种异型alternative pathway 旁路途径American type culture collection(ATCC)美国菌种保藏中心ammonification 氨化作用amphitrichaete 两端鞭毛菌anaerobe 厌氧菌anaerobic acetyl-CoA pathway 厌氧乙酰辅酶A途径又称活性乙酸途径anaerobic glove box 厌氧手套箱anaerobic jar 厌氧罐anamnestic response 回忆应答anastomosis 菌丝联结antibody 抗体antibody-dependent cell-mediated 抗体依赖性细胞介导的细胞毒作用cytotoxity(ADCC)antibody titer 抗体滴度antigen 抗原antigen binding fragment 抗原结合片断antigenic determinant 抗原决定簇或表位antigenic valence 抗原结合价antigenicity 抗原性antigen presenting cell 抗原呈递细胞antisepsis 防腐apothecium 子囊盘apparent infection 显性感染archae 古细菌artificial active immunization 人工自动免疫artificial immunization 人工免疫artificial passive immunization 人工被动免疫ascocarp 子囊果ascus 子囊ascus spore 子囊孢子assimilatory nitrate reduction 硝酸盐同化作用attenuated vaccine 减毒活疫苗autoantigen 自身抗原autolysis 自溶autotroph 自养型auxanography 生长谱法auxoautotrophs 自养型微生物auxohetertrophs 异养型微生物auxotroph 营养缺陷型bacillus 杆菌bacterial leaching 细菌沥滤bacteriocidation 杀菌bacteriolysis 溶菌bacteriophage 噬菌体bacteriorhodopsin 细菌视紫红质bacteroids 类菌体bactogen 恒化器bactoprenol 细菌萜醇barophiles 嗜压菌basal body 基体basophilie 嗜碱微生物basotolerant microorganism 耐碱微生物batch culture 单批培养或密封培养biofilm 生物膜birth scar 蒂痕bud scar 芽痕budding 芽殖burst size 裂解量capsid 衣壳capsomere(capsomer)衣壳粒capsule 荚膜carboxysome 羧化体carrier state 带菌状态caryoganmy 核配carbon source 碳源cellular immunity 细胞免疫cell wall 细胞壁cell membrane 细胞膜central immune organ 中枢淋巴器官或一级淋巴器官chemostat 恒化器chemotherapeutant 化学治疗剂chemotherapy 化疗chlamydia 衣原体chronic infection 慢性感染classes 类别classical pathway 经典途径cleistothecium 闭囊壳clone 细胞群或克隆closed culture 密封培养或单批培养cluster of differentiation(CD)分化群coagulase 血浆凝固酶coccus 球菌colicinogenic factor Col因子collagenase 胶原酶colony 菌落combined vaccine 联合疫苗common antigen 共同抗原competence 感受态complement 补体complement receptor 补体受体complementarity-determining region(CDR)互补性决定区又称高变区complete antigen 完全抗原complete medium 完全培养基complete transduction 完全转导complex medium 天然培养基conditional lethal mutant 条件致死突变型conformational eterminant 构象决定簇或不连续决定簇conjugant 接合子conjugation 接合constant region 恒定区或C区continuous autoclaving 连续加压灭菌法continuous determinan 连续决定簇或顺序决定簇continuous culture 连续培养或开放培养continuous fermentation 连续发酵core 核心corrosion 腐蚀cortex 皮层culturable 可培养的cyanobacteria 蓝细菌cyanophycin 藻青素cytoplasm 细胞质dead vaccine 死疫苗death phase 死亡期或衰亡期decay 腐朽decline phase 衰亡期或死亡期defective phase 缺陷噬菌体defined medium 组合培养基degeneration 衰退delayed type hypersensitivity initiator 迟发型超敏T细胞或迟发型T细胞denitrification 反硝化作用desulfuration 脱硫作用deterioration 变质differertial medium 鉴别培养基disconformational determinant 不连续表位或构象决定簇disinfection 消毒donor 供体菌double lysogen 双重溶源菌doubling time 倍增时间或代时downstream processing 下游工程dry hot sterilization 干热灭菌eclipse phase 隐晦期effective stage 效应阶段elementary body 原体endospore 芽孢endotoxin 内毒素enrichment culture 富集培养enriched medium 加富培养基Entner-Doudoroff pathway ED途径envelope 包膜enzyme-linked immunosorbent assay(ELISA)酶联免疫吸附试验epibiotic microbe 附生微生物episome 附加体epitope 表位或抗原决定簇exotoxin 外毒素exosporium 芽胞壁exponential phase 指数期或对数期extreme microorganism 极端微生物facultative aerobe 兼性厌氧菌fermentation 发酵fermenter 发酵罐fertility factor F因子fibrinolysin 血纤维蛋白溶即酶链激酶fimbria 菌毛fission 裂殖filament 鞭毛丝flagellum 鞭毛fluctuation test 变量试验forespore 前芽孢fractional heat sterilization 湿热灭菌framework region(FR)骨架区crystalisable fragment 可结晶片断或Fc片断fructification 子实体fruiting body 子实体fungus(复fungi)真菌gene-deleted vaccine 基因缺失疫苗generalized transduction 普遍转导generation time 代时或倍增时间group antigen 类属抗原growth curve 生长曲线growth factor 生长因子growth rate constant 生长速率常数halophiles 嗜盐菌hapten 半抗原haustorium 吸器heavy region 重链或H链heterocaryon 异核体heterocyte 异形孢heterogeneity 异质性或不均一性heterolactic fermentation 异型乳酸发酵hetertroph 异养型hexon 六邻体high frequency recombination 高频重组high frequency transduction 高频转导high temperature short time 高温瞬时法hinge chain 铰链区homolactic fermentation 同型乳酸发酵hook 鞭毛鞘humoral immunity 体液免疫hyaluronidase 透明质酸酶,又称扩散因子hypersensitivity 过敏反应或变态反应hypervariable region(HVR)高变区又称互补性决定区hyphae 菌丝immune response 免疫应答immunity 免疫性immunocyte 免疫细胞immunodiffusion tests 免疫扩散实验immunogen 免疫原immunogenicity 免疫原性immunoglobulin 免疫球蛋白immunological adjuvant 免疫佐剂,简称佐剂immunologic defence 免疫防御immunologic homeostasis 免疫稳定immunologic serveillance 免疫监视immunoreactivity 免疫反应性immuno tolerance 免疫耐受inapparent infection 隐性感染inclusion body 包涵体incomplete antigen 不完全抗原inductive stage 感应阶段infective centre 感染中心initial body 始体innate immunity 先天免疫又称非特异性免疫inoculum 接种interferon 干扰素interleukin 白细胞介素intracellular-accumulation phase 胞内累积期invastiveness 侵袭力isotype 同种型joining chain J链或连接链killer cell 杀伤细胞lag phase 延滞期或停滞期或适应期latent phase 潜伏期lawn 菌苔layer plating method 夹层培养法life cycle 生命周期或生活史lectin pathway of complement activation 凝集素途径lipopolysaccharide 脂多糖liquid medium 液体培养基live vaccine 活疫苗local infection 局部感染logarithmic phase 对数期或指数期lomasome 膜边体lophotrichaete 丛毛菌low frequency transduction 低频转导low temperature holding time 低温维持法lysis from without 自外裂解lysogen 溶源菌lysogenic phage 溶源噬菌体lysogenic conversion 溶源转变lysogeny 溶源性macrophage 巨噬细胞medium 培养基mendosicutes 疵壁菌mesosome 间体metachromatic granule 异染粒microaerophilic bacteria 微好氧菌microbiology 微生物学microcapsule 微荚膜microflora 微生物区系microorganism, microbe 微生物mildew 霉变minimal medium 基本培养基mitogen 有丝分裂原monoclonal antibody 单克隆抗体monotrichaete 单毛菌most probable number(MPN)最大可能数mo(u)ld 霉菌mouldness 霉变multiplicity of infection 感染复数mycelium 菌丝体mycoplasma 支原体natural killer cell 自然杀伤细胞即NK细胞net 菌网newcombe experiment 涂布试验nitrate respiration 硝酸盐呼吸nitrification 硝化作用nitrogenase 固氮酶nitrogen source 氮源nonculturable 不可培养的non-specific immunity 非特异性免疫又称先天免疫normal autoclaving 常规加压灭菌法normal flora 正常菌群nuclear body 核质体nucleic acid vaccine 核酸疫苗nuecleocapsid 核衣壳open culture 开放培养或连续培养parasexual hybridization 准性杂交parasexual reproduction 准性生殖parasexuality 准性生殖parasitism 寄生parasporal crystal 伴孢晶体pasteurization 巴氏消毒法pathogenicity 致病力penetration 侵入penton 五邻体peptidoglycan 肽聚糖peribacterial membrane 类菌体周膜peripheral immune organ 外周免疫器官periplasmic space 周质空间perithecium 子囊壳peritrichaete 周毛菌phage 噬菌体phenol coefficient(p.c)石炭酸系数phototroph 光能营养型phycobilisome 藻胆蛋白体phycocyanin 藻青蛋白pilus 菌毛plaque 噬菌斑plaque-forming unit (pfu)噬菌斑形成单位plasmid 质粒plastid 质体plateau 平稳期poly-β-hydroxybutyrate 聚-β-羟丁酸precipitation reaction 沉淀反应preservation 菌种保藏primary immune response 初次应答primary lymphatic organ 一级淋巴器官或中枢淋巴器官prion 朊病毒productive cycle 增殖性生活周期prophage 前噬菌体prototroph 原养型psychrophiles 嗜冷菌pure culture 纯培养物pure isolate 纯分离物pycnidium 分生孢子器radioimmunoassay(RIA)放射免疫分析recombinant-vector vaccine 载体疫苗rejuvenation 复壮relaxed replication control 松弛型复制控制replica plating 平板影印培养试验replication 增殖resistance factor R因子或抗性因子resistant mutant 抗性突变型restricted transduction 局限转导reversevaccinology 反向疫苗学rhizosphere microorganism 根际微生物rickettsia 立克次氏体rhizobium 根瘤菌rhizoid 假根rolling circle model 滚环复制rough 粗糙satellite virus 卫星病毒sclerotium 菌核secondary immune response 再次应答secretory piece 分泌片selected medium 选择培养基self tolerance 自身免疫耐受semi-defined medium 半组合培养基semi-solid medium 半固体培养基sequential determinant 顺序决定簇或连续决定簇serology 血清学sexduction 性导sex fimbria 性菌毛sex pilus 性菌毛single protein 单细胞蛋白slime layer 粘液层smooth 光滑solid medium 固体培养基specialized transduction 局限转导specific antigen 特异性抗原specific immunity 特异性免疫spirochaeta 螺旋体spirillum 螺菌spirilla 螺旋菌spontaneous lysis 自外裂解spore 芽孢sporangium 芽孢囊或孢子囊sporodochium 分生孢子座sporocarp 子实体spreading factor 扩散因子,现称透明质酸酶stationary phase 稳定期或恒定期、最高生长期sterilization 灭菌stolon 匍匐菌丝strain 菌株streptokinase 链激酶即血纤维蛋白溶酶strict aerobe 专性好氧菌stringent replication control 严紧型复制控制subclasses 亚类substrate mycelium 基质菌丝subtype 亚型sulfur oxidation 硫化作用superantigen 超抗原supplemental medium 补充培养基synochronous culture 同步培养synochronous growth 同步生长synthetic medium 合成或综合培养基systemic infection 系统感染teichoic acid 磷壁酸temperate phage 温和噬菌体thermophiles 嗜热菌thylakoid 类囊体thymus dependent antigen 胸腺依赖抗原thymus independent antigen 非胸腺依赖抗原titre 效价tolerogen 耐受原toxin 毒素toxoid 类毒素transduction 转导transfection 转染transformant 转化子transformation 转化transposible element 转座因子transposon 转座子或转位子、易位子tumor inducing plasmid Ti质粒turbidostat 恒浊器tyndallization 间歇灭菌法type 型type culture 典型菌种undefined medium 天然培养基vegetative mycelium 营养菌丝体vaccine 疫苗valency 结合价variable region 可变区或V区vibro 弧菌virion 病毒体或病毒粒子viroid 类病毒virulence 毒力virulent phage 烈性噬菌体virus 病毒water activity 水活度wild type 野生型xanthan 黄原胶或黄杆胶yeast 酵母菌zoogloea 菌胶团。
生物免疫学英文词汇汇总学习
医学免疫学英中文词汇Aaccessibility易接近性acetylcholine,Ach乙酰胆碱acquired immune deficiency syndrome,AIDS获得性免疫缺陷综合征(艾滋病)acquired tolerance获得性免疫耐受activation-induc ed cell death,AICD,活化诱导的细胞凋亡active immunotherapy主动免疫疗法acute phase protein,APP急性期蛋白acute rejection 急性排斥反应acute vascular rejection,AVR急性血管性排斥adaptive immune system适应性免疫系统adaptive immunity适应性免疫adenosinedeaminase,ADA腺苷脱氨酶adhesionmolecule,AM黏附分子adjuvant佐剂adoptive immunity过继免疫adult thymectomy,AT成年胸腺切除术affinity亲和力affinitymaturation(抗体)亲和力成熟agglutination凝集反应alkalinephosphatase,AP碱性磷酸酶allergen变应原allergicinflammation,AI变态反应炎症alloantigen同种异型抗原allograft同种异基因移植allotype同种异型alpha-fetoprotein,√廿P甲胎球蛋白alternativepathway旁路(替代)途径anaphylatoxin过敏毒素anaphylaxis过敏反应ankylosingspondylitis,AS强直性脊柱炎antibodydependentcell-mediatedcytotoxicity,ADCC抗体依赖性细胞介导的细胞毒作用antibody,Ab抗体,antigenpresentation抗原提呈antigenpresenting cell,APC抗原提呈细胞,antigen,Ag抗原,antigen-bindingfragment,Fab抗原结合片段,antigen-bindingsite抗原结合部位,antigenicdeterminant,AD抗原决定簇antigenic valence抗原结合价,antigenicity抗原性,anti-idiotype,Aid抗独特型anti—infectionimmunity抗感染免疫antiserum抗血清antitoxin抗毒素apoptosis细胞凋亡artificial activeimmunization人工主动免疫artificialantigen人工抗原artificialpassiveimmunization人工被动免疫ataxiatelangiectasia,AT 毛细血管扩张性共济失调综合征atopy特应性attenuatedvaccine减毒活疫苗autoantigen 自身抗原autograft 自体移植autoimmune disease 自身免疫病autoimmunity自身免疫avidin亲和素(抗生物素蛋白)avidity亲合力azoprotein偶氮蛋白Bp barrel p桶状p lysin乙型溶素B cell receptor,BCR B细胞受体basophil嗜碱粒细胞Bence-Jones protem本周蛋白bbfunction anibody,B{Ab双功能抗体Bioinformaties生物信息学biological response modifier,BRM 生物应答调节剂biotin生物素,biotin-avidinsystem,BAS生物素一亲和素系统bi-specificantibody,BsAb双特异抗体bone marrow骨髓bovine gammaglobulin,BGG牛丙种球蛋白bradykinin缓激肽bursa ofFabricius法氏囊bursa or bonemarfow dependentlymphocyte法氏囊或骨髓依赖的淋巴细胞(B细胞)CC reactionprotein,CRP C反应蛋白C1 inhibitor,C1INH C1抑制物C3b inactivatorC3b灭活因子(I因子)CA bindingprotein,CAbp CA结合蛋白Cadherin钙黏蛋白Calnexin钙联蛋白carcinoembryonicantigen,CEA癌胚抗原carrier载体carrier effect载体效应Caspase半胱天冬蛋白酶CD40 ligand,CD40LCIM0配体cell surfacemarker细胞表面标记cellularrejection细胞性排斥反应central immuneorgan中枢免疫器官central tolerance中枢耐受centroblast生发中心母细胞chemokine趋化因子chemotaxis趋化性chimeric antibody嵌合抗体chronic rejection慢性排斥反应class11-associatedinvariant chainpeptide,CLIP Ⅱ类相关的恒定链肽段classical pathway经典途径clonal anergy克隆无能clonal deletion克隆清除clonal selectiontheory克隆选择学说cluster ofdifferentiation,CD分化群codominance共显性collagen,CA胶原蛋白colony formingunit-culture,CFU-C体外培养集落形成单位colony formingunit-spleen,CFU-S 脾集落形成单位colonystimulating factor,CSF集落刺激因子committed stem cell定向干细胞common antigen共同抗原complement dependent cytotoxicity,CDC 补体依赖的细胞毒complement receptor,CR补体受体complement system 补体系统complement,C补体complementarity determining region,CDR互补决定区complete antigen 完全抗原concanavalin A,ConA刀豆蛋白Aconformational determinant构象决定簇conjugate vaccine 结合疫苗constant region,C区恒定区Coombs test抗球蛋白试验coreceptor共受体cortex皮质区co-stimulatorymoleculereceptor,CMR 协同刺激分子受体co-stimulatorymolecule,CM协同刺激分子cross-reaction交叉反应crystallizablefragment,Fe可结晶片段CTL antigen-4,Cn。
免疫学名词解释
名词解释(仅供参考)06预防二班1、现代的“免疫”概念:机体免疫系统识别和排除抗原性异物,对自身成分形成免疫耐受,以维持机体生理平衡与稳定的功能。
2、免疫学(immunology):是研究生理性免疫应答的过程和机制的科学;是研究免疫系统对自身抗原耐受,防止自身免疫病发生的科学;是研究免疫系统功能异常与相应疾病发病机制及其防治措施的科学。
3、淋巴细胞归巢:成熟细胞离开中枢免疫器官后,经血液循环趋向性迁移并定居与外周免疫器官或组织的特定区域,成为淋巴细胞归巢。
4、淋巴细胞再循环:淋巴细胞(T、B)经淋巴循环及血液循环,运行并再分布于全身淋巴组织中。
5、免疫细胞:指所有参与免疫应答,或与免疫应答有关的细胞。
包括淋巴细胞: T、B;单核吞噬细胞;抗原呈递细胞;自然杀伤细胞(NK细胞);粒细胞;肥大细胞;红细胞、血小板等。
6、.抗原的概念:是指能刺激机体的免疫系统产生特异性免疫应答,并能与免疫应答的产物(抗体或致敏淋巴细胞)在体内外特异性结合的物质。
7、免疫原性:能刺激机体产生免疫应答的能力(产生抗体或致敏T细胞)。
8、抗原性:能与抗体或致敏淋巴细胞发生特异性结合的能力。
9、耐受原:引起免疫耐受的抗原。
10、变应原:引起变态反应(超敏反应)的抗原。
11、抗原表位(抗原决定基)antigenic determinant :抗原分子中决定抗原特异性的特殊化学基团。
一种抗原决定基(表位)决定一种特异性,可刺激机体产生一种相应的抗体。
12.、超抗原(Superantigen,SAg):极低浓度即可激活较多的T细胞克隆,产生极强的免疫应答,这类抗原称为超抗原。
13、异嗜性抗原(heterophilic antigen):是一类与种属无关的存在于人、动物及微生物之间的共同抗原。
14、半抗原:仅具有抗原性而没有免疫原性的物质。
15、佐剂(adjuvant):属非特异免疫增强剂,与抗原一起或预先注入机体后,可增强机体对抗原的免疫应答能力,或改变免疫应答类型,此物质称免疫佐剂。
免疫学名词简答总结
第一章、绪论一、名词解释★免疫(immunity):是机体免疫系统识别“自身”和“非己”,对“自身”耐受,对“非己”排除的一种生理功能。
二、简答题简述固有免疫与适应性免疫的比较。
固有免疫适应性免疫获得形式固有性(先天性)无需抗原激发获得性免疫需要抗原激发发挥作用时相早期,快速(数分钟至4天)4~天后发挥效应免疫原识别受体模式识别受体特异性抗原识别受体由于细胞发育中基因重拍产生多样性免疫记忆无有,产生记忆细胞举例抑菌、杀菌物质,补体,炎症因子吞噬细胞,NK细胞,NKT细胞T细胞(细胞免疫-效应T细胞)B细胞(体液免疫-抗体)第二章、免疫器官和组织一、名词解释★1、淋巴细胞归巢(lymphocyte homing):是指血液中的淋巴细胞选择性趋向迁移并定居于外周免疫器官的特定区域或特定组织的过程。
★2、淋巴细胞再循环(lymphocyte recirculation):是指定居在外周免疫器官的淋巴细胞,由输出淋巴管经淋巴干、胸导管或右淋巴导管进入血液循环;经血液循环到达外周免疫器官后,穿越HEV,重新分布于全身淋巴器官和组织的反复循环过程。
二、简答题★简述中枢免疫器官和外周免疫器官的组成及功能。
1、中枢免疫器官▲骨髓:①各类血细胞和免疫细胞发生的场所。
②B细胞和NK细胞分化成熟的场所。
③体液免疫应答发生的场所。
▲胸腺:①T细胞分化、成熟的场所。
②免疫调节作用。
③自身耐受的建立与维持。
2、外周免疫器官▲淋巴结:①T细胞和B细胞定居的场所。
②免疫应答发生的场所。
③参与淋巴细胞再循环。
④过滤作用。
▲脾:①T细胞和B细胞定居的场所。
②免疫应答发生的场所。
③合成生物活性物质。
④过滤作用。
⑤贮存和调节血量(非免疫功能)。
▲黏膜相关淋巴组织:①行使黏膜局部免疫应答。
②产生分泌型IgA(SIgA)。
第三章、抗原一、名词解释★1、抗原(antigen,Ag):是指所有能激活和诱导免疫应答的物质。
通常指能(1)被T、B淋巴细胞表面特异性抗原受体(TCR或BCR)识别及结合,激活T、B 细胞增殖、分化、产生免疫应答效应产物(特异性淋巴细胞或抗体),(2)并与效应产物结合,进而发挥适应性免疫应答效应的物质。
免疫学复习思考题
免疫学复习思考题(总19页)--本页仅作为文档封面,使用时请直接删除即可----内页可以根据需求调整合适字体及大小--免疫学复习思考题考试题型:Ⅰ名词解释(每小题4分,共24分)Ⅱ、单项选择题(每小题2分,共30分)Ⅲ、简答题(每题3分,共24分)Ⅳ、问答题(共两题,共22分)考试时间:第12周,周三2:00-4:00。
一、名词解释1.免疫(immunity)是机体识别“自己”, 排除“异己(非己)”过程中所产生的生物学效应的总和,正常情况下是维持内环境稳定的一种生理性防御功能。
2.抗原(antigen,Ag)凡能刺激机体免疫系统产生特异性免疫应答,并能与相应的免疫应答产物(抗体或效应性T淋巴细胞)在体内或体外发生特异性结合的物质称为抗原。
3.抗原决定簇 (antigenic determinant) 又称表位(epitope),指存在于抗原分子表面,决定抗原特异性的特殊化学基团。
它是TCR/BCR及抗体特异结合的基本单位。
其性质、数目和空间构象决定抗原的特异性。
4.半抗原(hapten)又称不完全抗原(incomplete antigen)仅有免疫反应性,不具免疫原性,但与大分子蛋白质或非抗原性的多聚赖氨酸等载体交联或结合后可获得免疫原性,诱导免疫应答。
5.超抗原(superantigen,SAg)是一类可直接结合抗原受体,激活大量T细胞或B细胞克隆,并诱导强烈免疫应答的物质。
它所诱导的细胞应答并非针对超抗原本身,而是通过非特异性激活免疫细胞分泌大量炎症性细胞因子,导致中毒性休克、多器官衰竭等严重病理过程的发生。
它分为外源性超抗原:如金葡菌肠毒素;内源性超抗原:如病毒蛋白等。
6.异嗜性抗原(heterophile antigen)又称Forssman抗原,指在不同种属动物,植物,微生物细胞表面上存在的共同抗原。
例如,溶血性链球菌的表面成分与人肾小球基底膜及心肌细胞组织存在共同抗原,故链球菌感染机体产生的抗体可与具有共同抗原的心、肾组织发生交叉反应,导致肾小球肾炎或心肌炎;大肠埃希菌O14型脂多糖与人结肠粘膜有共同抗原,可导致溃疡性结肠炎的发生。
免疫学名词解释
1.antigen(Ag):抗原,是指与TCR/BCR或抗体结合,具有启动免疫应答潜能的物质。
2.hapten:半抗原,又称不完全抗原,是指仅具有与抗体结合的能力,而单独不克不及诱导抗体发生的物质。
当半抗原与蛋白质载体结合后即可成为完全抗原。
3.super antigen(SAg):超抗原,是指在极低浓度下即可非特异性激活大量T细胞克隆增殖,发生极强的免疫应答,但又分歧于丝裂原作用的抗原物质。
该抗原能刺激T细胞库总数的1/20~1/5,且不受MHC限制,故成为超抗原。
4.antibody(Ab):抗体,是B细胞特异性识别Ag后,增殖分化成为浆细胞,所合成分泌的一类能与相应抗原特异性结合的、具有免疫功能的球蛋白。
5.immunoglobulin(Ig):免疫球蛋白,是指具有抗体活性或化学结构与抗体相似的球蛋白,可分为分泌型和膜型。
6.hypervariable region(HVR):高变区,在Ig分子VL和VH内某些区域的氨基酸组成、排列顺序与构型极易变更,这些区域为高变区。
7.variable region(V):可变区,在Ig多肽链氨基端(N端),L链1/2与H链1/4区域内,氨基酸的种类、排列顺序与构型变更很大,故称为可变区。
8.monoclonal Ab(mAb或McAb):单克隆抗体,是由识别一个抗原决定簇的B淋巴细胞杂交瘤分裂而成的单一克隆细胞所发生的高度均一、高度专一性的抗体。
9.antibody-dependent cell-mediated cytotocity(ADCC):ADCC效应,即抗体依赖性细胞介导的细胞毒作用,是指表达Fc受体的细胞通过识别抗体的Fc段直接杀伤被抗体包被的靶细胞的作用。
NK细胞是介导ADCC效应的主要细胞。
10.opsonization:调理作用,是指IgG抗体(特别是IgG1和IgG3)的Fc段与中性粒细胞、巨噬细胞上的IgGFc受体结合,从而增强吞噬细胞的吞噬作用。
医学免疫学英文词汇知识
AAcquired immune deficiency syndrome, AIDS 获得性免疫缺陷综合征(艾滋病) Acquired immunity 获得性免疫Activation induced cell death, AICD 活化诱导的细胞死亡Active immunotherapy 主动免疫治疗Acute phase protein 急性时相蛋白Adapter 转接蛋白Adaptive immunity 适应性免疫Addressin 地址素Adenosine deaminase 腺苷脱氨酶Adjuvant 佐剂Adoptive immunity 过继免疫Adoptive immunotherapy, AIT 过继免疫治疗Affinity 亲和力Affinity maturation 亲和力成熟Agglutination 凝集反应Allelic exclusion 等位排斥Allergen 变应原Allergin 变应素Allergy 变态反应Allogenic antigen 同种异型抗原Allograft 同种异型移植Allotype 同种异型Allorecognition 同种异型识别Alpha-fetoprotein, AFP 甲种胎儿球蛋白Alternative pathway 旁路途径Anamnestic response 回忆应答Anaphylactic shock 过敏性休克Anaphylactogen 过敏原Anaphylaxis 过敏反应Anchor residue 锚定残基Ankylosing spondylitis, AS 强直性脊柱炎Antibacterial immune serum 抗菌免疫血清Antibody, Ab 抗体Antibody-dependent cell-mediated cytotoxicity, ADCC 抗体依赖性细胞介导的细胞毒作用Antiviral immune serum 抗病毒免疫血清Antigen, Ag 抗原Antigenic determinant 抗原决定簇Antigen internal image 抗原内影像Antigen-presenting cells, APC 抗原提呈细胞Antigen specific immune response 抗原特异性免疫应答Antigenicity 抗原性Anti-idiotype 抗独特型Antitoxic serum 抗毒素血清Apoptosis 细胞凋亡Apoptosis cell associated molecular pattern, ACAMP凋亡细胞相关的分子模式 Apoptotic body 凋亡小体Artificial active immunization 人工主动免疫Artificial passive immunization 人工被动免疫Ataxia telangiectasia syndrome, AT 毛细血管扩张共济失调综合征 Atopic dermatitisAutocrineAutograftAutoimmune antibodyAutoimmune disease, AIDAutoimmune hemolytic anemiaAutoimmune thrombocytopenic purpuraAutoimmunityBBacillus Calmette Guerin, BCGBare lymphocyte syndrome, BLSBasophilB cell epitope BB cell hybridoma BB cell linker ptotein, BLNKB cell receptor, BCRBiotin-avidin system, BASBispecific antibody, BsAbBlocking antibodyB lymphocyteBone marrowBone marrow transplantation, BMTBradykininCC1 inhibitor, C1 INHC4 binding protein,C8 binding protein, C8bpC-reactive protein,CRPCadherinCalcineurinCalmodulinCarcinoembryonic antigen, CEACarrierCecropinsCell adhesion molecules, CAM 特应性皮炎自分泌自体移植自身抗体自身免疫性疾病自身免疫性溶血性贫血自身免疫性血小板减少性紫癜自身免疫卡介苗裸淋巴细胞综合征嗜碱性粒细胞细胞表位细胞杂交瘤 B 细胞连接蛋白 B 细胞(抗原识别)受体生物素-亲和素系统双特异性抗体封闭抗体 B淋巴细胞骨髓骨髓移植缓激肽C1抑制分子 C4bp C4 结合蛋 C8 结合蛋白 C-反应蛋白钙粘蛋白钙神经素(钙调磷酸酶)钙调蛋白癌胚抗原载体杀菌肽细胞粘附分子hediak-Higashi syndrome Chediak-Higashi综合征 Chemokine 趋化性细胞因子 Chimeric antibody 嵌合抗体Chronic granulomatous disease, CGD 慢性肉芽肿病 Class Ⅱtransactivator, C ⅡTA Ⅱ类反式活化子 Class switch 类别转换Classical pathway 经典途径Clonal anergy 克隆无能Clonal deletion 克隆删除Clonal eliminationClonal expansionCluster of differentiation, CDColony stimulating factor, CSFCommon variable immunodeficiencyComplementComplement deficiencyComplement receptorComplementarity determining region, CDRComplete antigenConcanavalin A, Con AConformational determinantConstant regionCo-receptorCo-stimulating signalCo-stimulatory molecules, CMCo-stimulatory molecule receptor, CMR Cross reactionCryptic determinantCytokine, CKCytolytic typeCytotoxic typeCytotoxic T lymphocytes, CTL 或 Tc Cytotoxic T lymphocytes antigen-4, CTLA-4 DDecay accelerating factor, DAFDefensinsDelayed type hypersensitivity, DTHDelayed type hypersensitivity T cell, T DTH Dendritic cells, DCDiGeorge syndromeDiversity geneDNA vaccineDonorDouble immunodiffusion 克隆消除克隆扩增分化群集落刺激因子普通变化型免疫缺陷病补体补体缺陷补体受体互补性决定区完全抗原刀豆蛋白A 构象决定基恒定区,C区辅助受体协同刺激信号协同刺激分子协同刺激分子受体交叉反应隐蔽决定基细胞因子细胞溶解型细胞毒型细胞毒性T细胞细胞毒性T淋巴细胞(相关)抗原 4 衰变加速因子防御素迟发型超敏反应迟发型超敏反应性T细胞树突状细胞 DiGeorge综合征 D(多样化)基因 DNA疫苗供者双向免疫扩散Double negative cell, DN cell 双阴性细胞Double positive cell, DP cell 双阳性细胞EE rosette test E 花结试验Early phase reaction 早期相反应Endocytosis 胞吞作用Enzyme immunoassay, EIA 酶免疫测定Enzyme linked immunosorbent assay, ELISA 酶联免疫吸附试验Eosinophil, Eos 嗜酸性粒细胞Eosinophil chemotactic factor, ECF 嗜酸性粒细胞趋化因子Eosinophil peroxidase, EPO 嗜酸性粒细胞过氧化物酶 Epitope 表位Erythropoietin, EPO 红细胞生成素Extracellular matrix, ECM 细胞外基质F Fc receptor, FcR 结晶片断受体,Fc受体 Flow cytometry, FCM 流式细胞术Fluorescence-activated cell sorter, FACS 荧光活化细胞分类器 Follicular dendritic cells, FDC 滤泡树突状细胞 Fragment antigen binding, Fab 抗原结合片断Fragment crystallizable, Fc 结晶片断Fragment of variable region Fv 片断Framework region 骨架区Freund complete adjuvant 弗氏完全佐剂GGenetic engineering antibody 基因工程抗体Germ line gene 胚系基因Germinal center 生发中心Glycosylphosphatidylinositol, GPI 糖磷脂酰肌醇Graft versus host reaction, GVHR 移植物抗宿主反应 Granule exocytosis 颗粒胞吐Granulocyte colony stimulating factor, G-CSF 粒细胞集落刺激因子 Granulocyte-macrophage colony stimulating factor, GM-CSF 粒细胞-巨噬细胞集落刺激因子 Granzyme, Gz 颗粒酶Grave disease 毒性弥漫性甲状腺炎 Growth factor 生长因子Growth factor receptor binding protein-2,Grb-2 生长因子受体结合蛋白 2 Guanine nucleotide exchange factor, GEF 鸟苷酸置换因子Gut-associated lymphoid tissue, GALT 肠伴随(相关)淋巴组织 HHaplotype 单元型Hapten 半抗原Hashimoto’s thyroiditis 桥本甲状腺炎Heat shock protein, HSP 热休克蛋白Heavy chain 重链,H 链Helper T cells(lymphocytes), Th 辅助性 T 细胞 Hemolytic plaque assay 溶血空斑试验 Hemopoietic stem cell, HSC 造血干细胞 Heterophil antigen 异嗜性抗原 Hidden antigen 隐蔽抗原High endothelial venule, HEV 高内皮细胞小静脉 Hinge region 铰链区Histamin 组胺Histocompatibility antigen-2, H-2HLA genotypingHomologous restriction factor, HRFHost versus graft reaction, HVGRHuman immunodeficiency virus, HIVHuman leukocyte antigen,HLAHumanized antibodyHumoral immunity Hypersensitivity Hypervariable region, HVRIIdiotype, IdIdiotype networkImmediate hypersensitivity Immune adherent, IAImmune complex, ICImmune function related gene Immune regulationImmune responseImmune response region Immune serumImmune surveillanceImmune systemImmunityImmunocyteImmunodeficiency disease, IDD Immunofluorescence Immunogenicity'\ Immunoglobulin, IgImmunoglobulin superfamily, IgSFImmunohistochemistry techniqueImmunological competenceImmunological ignorance , ;Immunological toleranceImmunological non-responsiveness 小鼠的组织相容性抗原HLA 基因分型同源限制因子宿主抗移植物反应人类免疫缺陷病毒人类白细胞抗原人源化抗体体液免疫超敏反应高变独特型独特型网络速发型超敏反应免疫粘附免疫复合物免疫功能相关基因免疫调节免疫应答免疫应答区免疫血清免疫监视免疫系统免疫免疫细胞免疫缺陷病免疫荧光法免疫原性免疫球蛋白免疫球蛋白超家族免疫组化技术免疫适能免疫忽视免疫耐受免疫不应答Immunologically privileged sites 免疫隔离部位Immunology 免疫学Immunoreceptor tyrosine-based activation motifs, ITAM 免疫受体酪氨酸活化基序 Immunoreceptor tyrosine-based inhibitory motifs, ITIM 免疫受体酪氨酸抑制基序 Immunotherapy 免疫治疗Inactivated vaccine 灭活疫苗Inducible nitric oxide synthase, iNOS 诱导型一氧化氮合成酶Inflammatory cell 炎症细胞Innate immunity 固有(性)免疫'\ Inositol-1, 4, 5-trisphosphate,IP3Insulin-dependent diabetes mellitus, IDDMIntercellular adhesion molecular,ICAMIntegrinInterferon, IFNInterleukin, ILInternalizationImtraepithelial lymphocytes, IELJJoining chainJoining geneKKiller activatory receptor, KARKiller inhibitory receptor, KIRKiller immunoglobulin like receptorKininogenaseLLangerhans cells, LCLarge granular lymphcytes, LGLsLate phase reactionLectinLectin-like carbohydrate recognition domain, CRDLeucine rich repeat, LRRLeukinLeukocyte adhesion deficiency, LADLeukocyte common antigen, LCALeukocyte differentiation antigen, LDALeukotrienes (Leucotrienes), LTsLigandLight chainLinker for activation of T cell, LATLinear determinantLinkage disequilibriumLipoteichoic acid, LTALipoxygenase pathway 三磷酸肌醇胰岛素依赖型糖尿病细胞间粘附分子整合素干扰素白细胞介素内化上皮细胞间淋巴细胞 J链J基因杀伤细胞活化受体杀伤细胞抑制受体杀伤细胞免疫球蛋白样受体激肽原酶郎格汉斯细胞大颗粒淋巴细胞晚期相反应凝集素凝集素样糖识别结构域富含亮氨酸的重复序列白细胞素白细胞粘附缺陷白细胞共同抗原白细胞分化抗原白三烯配基,配体轻链,L 链 T细胞活化连接蛋白线性决定基连锁不平衡磷壁酸脂氧合酶途径Live-attenuated vaccine 减毒活疫苗Long-acting thyroid stimulator, LATS 长效甲状腺刺激素Low molecular-weight polypeptide, LMP 低分子量多肽LPS binding protein, LBP LPS结合蛋白Lymphocyte 淋巴细胞Lymphocyte function associated antigen, LFA 淋巴细胞功能相关抗原 Lymphocyte homing 淋巴细胞归巢Lymphocyte homing receptor, LHR 淋巴细胞归巢受体Lymphoid DC 淋巴系树突状细胞Lymphoid progenitor 淋巴样祖细胞Lymphoid stem cells, LSC 淋巴样干细胞Lymphokine, LK 淋巴因子Lymphokine activated killer cell, LAK 淋巴因子激活的杀伤细胞 Lymphotoxin, LT 淋巴毒素β -lysin 乙型溶素Lysosome-associated membrane proteins-1,LAMP-1 溶酶体相关膜蛋白1 Lysozyme 溶菌酶MMacrophages, M φ 巨噬细胞Macrophage colony stimulating factor, M-CSF 巨噬细胞集落刺激因子 Macropinocytosis 巨吞饮Magainins 爪蟾抗菌肽Major histocompatibility complex, MHC 主要组织相容性复合体 Mannan-binding lectin, MBL 甘露糖结合凝集素Mannose binding protein, MBP 甘露糖结合蛋白Mannose receptor, MR 甘露糖受体Mast cell, MC 肥大细胞MBL-associated serine protease, MASP MBL 伴随的丝氨酸蛋白酶 Membrane attack complex, MAC 膜攻击复合物Membrane cofactor protein, MCP 膜辅助因子蛋白Membrane Ig, mIg 膜表面免疫球蛋白Membrane inhibitor of reactive lysis, MIRL 膜反应性溶解抑制物 Memory cells 记忆细胞MHC class Ⅰgene MHC Ⅰ类基因MHC class Ⅱgene MHC Ⅱ类基因MHC class Ⅲgene MHC Ⅲ类基因MHC restriction MHC 限制性Microfold cell M细胞,微小褶皱细胞β 2-Microglobulin, β2 -m β2 微球蛋白Minor histocompatibility antigen 次要组织相容性抗原 Mitog en 丝裂原Mitogen-activation protein kinase, MAPK 丝裂原激活蛋白激酶 Molecular mimicry 分子模拟Monoclonal antibody, McAb 单克隆抗体第7 / 11页Monocyte 单核细胞Monocyte chemotactic protein, MCP 单核细胞趋化蛋白Monokine, MK 单核因子Mononuclear-phagocyte system, MPS 单核-巨噬细胞系统Mucosal-associated lymphoid tissue, MALT 粘膜伴随(相关)淋巴组织 Mucosal mast cell, MMC 粘膜肥大细胞Multiple hematopoietic stem cells, HSC 多能造血干细胞Multiple sclerosis, MS 多发性硬化症Myasthenia gravis, MG 重症肌无力Myeloid DCMyeloid stem cellMyeloperoxidase, MPONNaive T(B) cellsNatural cytotoxic cellNature killer cell, NK cellNeutrophilsNitric oxide, NONitroblue tetrazolium, NBTNon-classical MHC class ⅠgeneNon-organ specific autoimmune diseaseNon-specific immunityNude miceOOpsonizationOrgan specific autoimmune diseasePParacrineParoxysmal nocturnal hemoglobineria, PHNPassive immunotherapy ,Passive transfer of lymphocytePathogen associated molecular pattern, PAMPPattern recognition receptor, PRRPeptide antibioticsPeptidoglycan, PGNPerforinPeripheral lymphoid organPeyer’s patchesPhagocytePhagocytosisPhagolysosomePhosphatidylinnosital pathway 髓系树突状细胞髓样干细胞髓过氧化物酶初始T(B)细胞自然细胞毒性细胞自然杀伤细胞嗜中性粒细胞一氧化氮氮蓝四唑非经典性Ⅰ类基因非器官特异性自身免疫病非特异性免疫裸小鼠,裸鼠调理作用器官特异性自身免疫病旁分泌夜间血红蛋白尿被动免疫治疗淋巴细胞被动转移病原相关分子模式模式识别受体肽抗菌肽聚糖穿孔素外周淋巴器官派氏集合淋巴结吞噬细胞吞噬作用吞噬溶酶体 PI途径第8 / 11页Phosphatidylinositol-3-kinase, PI3-K 磷脂酰肌醇3激酶Phosphatidylinositol-4,5-bisphosphate, PIP 2 磷脂酰肌醇4,5二磷酸 Phosphatidylinositol-3,4,5-trisphosphate 磷脂酰肌醇3,4,5三磷酸 Phosphatidylserine, PS 磷脂酰丝氨酸Phosphoinositides 磷酸肌醇Phospholipase 磷脂酶Phospholipid bilineurine 磷脂胆碱Phosphotylinositide-3 kinase 磷酸肌醇-3激酶Phytohemagglutinin, PHA 植物血凝素PinocytosisPinocytotic vesiclePlacental γ globulinPlaque forming cell, PFCPlasma cellsPlatelet activating factor, PAFPolymeric Ig receptor, pIgRPolymorphismPolymorphic genesPolymorphonuclear neutrophils, PMN PrecipitationPrimary immunodeficiency disease, PIDD Primary responsePro-B cellprofessional antigen presenting cells Programmed cell death, PCDProperdin, PProstaglandin, PGProtein kinase C, PKCProtein tyrosine kinase, PTKProtein tyrosine phosphatase, PTP/PTPase Proteolytic enzyme complexProteosomePurine nucleotide phosphorylase, PNPRγδ+T cellRadioimmunoassay, RIAReactive nitrogen intermediates, RNIs Reactive oxygen intermediates, ROIs RearrangementReceptor editingReceptor-mediated endocytosisRecipientRecombinant antigen vaccineRecombinant vector vaccine 胞饮作用吞饮泡胎盘丙种球蛋白空斑形成细胞浆细胞血小板活化因子多聚免疫球蛋白受体多态性多态性基因多形核嗜中性粒细胞沉淀反应原发性免疫缺陷病初次应答祖B细胞专职抗原提呈细胞程序性细胞死亡备解素前列腺素蛋白激酶C 蛋白酪氨酸激酶蛋白酪氨酸磷酸酶蛋白水解酶复合体蛋白酶体嘌呤核苷磷酸化酶γδ+T细胞放射免疫测定法反应性氮中间物反应性氧中间物(基因)重排受体编辑受体介导的胞吞作用受者重组抗原疫苗重组载体疫苗第9 / 11页Recombinase 重组酶Recombination activating genes, RAG 重组活化基因Recombination signal sequences, RSS 重组信号序列Rejection (移植物的)排斥Rheumatoid arthritis, RA 类风湿性关节炎Rheumatoid factor, RF 类风湿因子SScavenger receptor, SR 清杂受体Secondary immunodeficiency disease, SIDD 继发性免疫缺陷病Secondary response 再次应答Secretory component, SC 分泌成分,分泌小体Secretory IgA, sIgA 分泌型免疫球蛋白 ASecretory piece, SP 分泌片Selectin 选择素Selective IgA deficiency 选择性IgA缺陷Serin/threonine phosphatase 丝/苏氨酸磷酸酶Serum amyloid pretein A, SAA 血清淀粉样蛋白 ASevere combined-immunodeficiency disease, SCID 重症联合免疫缺陷病 Signal transduction 信号转导Signal transducers and activator of transcription, STAT 信号转导和活化转录因子 Signalling complex 信号复合体Single immunodiffusion 单向免疫扩散Small G protein 小 G 蛋白Sneaking through 漏逸Soluble TNF receptor, sTNFR 可溶性TNF受体Somatic hypermutation 体细胞高(频)突变Specific immunity 特异性免疫Split tolerance 耐受分离Src family kinase Src家族激酶Staphylococcus enterotoxin, SE 葡萄球菌肠毒素Staphylococcus protein A, SPA 葡萄球菌蛋白 AStem cell factor, SCF 干细胞(生长)因子Subunit vaccine 亚单位疫苗Superantigen, SAg 超抗原Suppressor T cells, Ts 抑制性T细胞Syngraft 同种基因移植,同型移植 Synthetic peptide vaccine 合成肽疫苗Systemic lupus erythematosus, SLE 系统性红斑狼疮TT cell epitope T细胞表位T cell receptor, TCR T细胞(抗原识别)受体 T lymphocyte T 淋巴细胞TCR/CD3 complex TCR/CD3 复合物Terminal deoxynucleotidyl transferase, TdT 末端脱氧核苷酸转移酶第10 / 11页Terminal pathway 末端通路Thrombopoietin 血小板生成素Thymic stromal cells, TSC 胸腺基质细胞Thymocyte 胸腺细胞Thymus 胸腺Thymus dependent antigen, TD-Ag 胸腺依赖抗原Thymus epithelial cells, TEC 胸腺上皮细胞Thymus independent antigen, TI-Ag 非胸腺依赖抗原Thyroid stimulating hormone, TSH 促甲状腺激素Tolerogen 耐受原Toll like receptor, TLR Toll样受体Toxoid &nbs, p; 类毒素Transforming growth factor, TGF 转化生长因子Transporters associated with antigen processing,TAP 抗原处理相关转运蛋白 Tumor-associated antigen, TAA 肿瘤相关抗原Tumor necrosis factor, TNF 肿瘤坏死因子Tumor-specific antigen, TSA 肿瘤特异性抗原VVariable folding 可变折叠Variable geng V基因Variable region ( V region ) 可变区,V区Vitronectin 玻璃连接蛋白,玻连蛋白 Very late appearing ant igen, VLA 迟现抗原WWestern blotting 免疫印迹法Wiskott-Aldrich syndrome, WAS 伴湿疹血小板减少性免疫缺陷病 XX-linked agammaglobulinemia, XLA 性联无丙种球蛋白血症 X-l inked hyperimmunoglobulin M syndrome, HIM 性联高IgM综合征 X-l inked SCID, XSCID 性联重症联合免疫缺陷病。
医学免疫学名词解释
医学免疫学名词解释第一章免疫学概论免疫(immunity):即免除疫病和抵抗疾病的发生。
是机体识别“自己”, 排除“异己(非己)”过程中所产生的生物学效应的总和,正常情况下是维持内环境稳定的一种生理性防御功能。
免疫系统(immune system):由免疫器官和组织、免疫细胞、,免疫分子及淋巴循环网络组成,是机体执行免疫应答和行使免疫功能的重要系统。
免疫防御(immunological defense):书:指机体防御及清除病原体的功能。
Ppt:防止外界病原体的入侵及清除已入侵的病原体及有害的生物性大分子。
免疫功能过高-超敏反应;过低-免疫缺陷症。
免疫监视(immunological surveillance):是指免疫系统识别、监视并清除体内出现的突变细胞的功能。
免疫监视功能的异常可导致肿瘤的发生或持续性的病毒感染。
免疫自稳(immunological homeostasis):是指免疫系统清除体内衰老、损伤的细胞或其他成分,通过免疫网络调节免疫应答平衡的功能。
免疫自稳功能异常可导致自身免疫性疾病。
免疫应答(immune response):是指机体的免疫细胞对抗原物质进行识别,继而活化、增值、分化,产生效应的过程,是多细胞系及多种免疫分子间相互作用的结果。
第二章 免疫器官和免疫组织1.免疫细胞(immune cells):参与免疫应答或与免疫应答有关的细胞,如T细胞、B细胞、单核巨噬细胞等。
2.淋巴细胞归巢(lymphocyte homing):成熟淋巴细胞的不同亚群从中枢免疫器官进入外周淋巴组织后,可分布在各自特定的区域,称为淋巴细胞归巢。
其分子基础是淋巴细胞归巢受体与内皮细胞上地址素之间的相互作用。
3.淋巴细胞再循环(lymphocyte recirculation):淋巴细胞在血液、淋巴液和淋巴器官之间反复循环,称为淋巴细胞再循环。
淋巴细胞在机体内的迁移和流动是发挥免疫功能的重要条件。
医学免疫学名词解释(全)
目录第一、二章、概论及免疫器官和组织 (1)第三章、抗原 (4)第四章、抗体 (1)第五章、补体系统 (4)第六章、细胞因子 (1)第七章、白细胞分化抗原和黏附分子 (4)第八章、主要组织相容性复合体 (1)第九章、B淋巴细胞 (4)第十章、T淋巴细胞 (1)第十一章、抗原提呈细胞与抗原的加工及提成 (4)第十二章、T淋巴细胞介导的适应性免疫应答 (1)第十三章、B淋巴细胞介导的特异性免疫应答 (4)第十四章、固有免疫系统及其介导的应答 (1)第十五章、免疫耐受 (4)第十六章、超敏反应 (1)第十七章、免疫学检测与防治 (4)医学免疫学名词解释(全)第一、二章、概论及免疫器官和组织1.医学免疫学:研究人体免疫系统的结构和功能的科学。
2.免疫防御:体内免疫系统防止外界病原体入侵或清除已入侵病原体及其他有害物质的功能。
3.免疫监视:体内免疫系统随时发现和清除体内出现的非几成分的功能。
4.免疫自身稳定:体内免疫系统通过自身免疫耐受和免疫调节两种主要机制来达到免疫系统内环境稳态的功能。
5.免疫应答:免疫系统识别和清除非己物质的整个过程。
6免疫(immunity):机体识别和排除抗原性异物(免疫防御+免疫监视),对自身成分形成耐受,维持机体生理平衡和稳定的功能(免疫自身稳定)。
7.中枢免疫器官:是免疫细胞发生、分化、发育和成熟的场所。
人或其他哺乳类动物的中枢免疫器官包括骨髓和胸腺。
8.骨髓:各类血细胞的发源地,也是人和哺乳动物B细胞发育成熟的场所。
9.胸腺:T细胞分化、发育、成熟的场所。
10.外周免疫器官:成熟淋巴细胞成熟的场所,也是各类淋巴细胞对外来抗原产生免疫应答的主要部位。
外周免疫器官和组织包括淋巴结、脾和粘膜相关淋巴组织等。
11.免疫系统:由免疫器官、免疫细胞和免疫分子组成,其功能是执行免疫功能。
第三章、抗原1.抗原(antigen,Ag):能够刺激机体产生特异性免疫应答,并能与效应产物发生特异性结合的物质。
(完整版)医学免疫学名词解释
医学免疫学名词解释1.免疫(immunity):机体能够识别“自己”和“异己”,并最终排除“异己”,保护“自己”,维持机体生理功能的稳定。
2.淋巴细胞归巢(lymphocyte homing):成熟淋巴细胞离开中枢免疫器官后,在循环过程中趋向性迁移并定居于外周免疫器官或不同组织的特定区域。
3.淋巴细胞再循环(lymphocyte recirculation):淋巴细胞在血液、淋巴液、淋巴器官或组织间反复循环的过程。
5.抗原(antigen,Ag):是指能与T淋巴细胞、B淋巴细胞的TCR或BCR结合,促使其增殖、分化,产生抗体或致敏淋巴细胞,并与之结合,进而发挥免疫效应的物质。
6.抗原表位(epitope):抗原分子中决定抗原的特异性的特殊化学基团,又称抗原决定簇(antigenic determinant)。
7.交叉反应(cross-reaction):抗体或致敏淋巴细胞结合具有相同和相似抗原表位的不同抗原分子所产生的免疫反应。
8.胸腺依赖性抗原(thymus dependent antigen,TD-Ag):此类抗原刺激B细胞产生抗体时依赖T细胞的辅助,故又称T细胞依赖性抗原。
【示例】TD-Ag:即胸腺依赖性抗原(1分)。
此类抗原刺激B细胞产生抗体时依赖于T 细胞辅助(1分)。
绝大多数蛋白质抗原均属此类抗原(1分)。
9.胸腺非依赖性抗原(thymus independent antigen,TI-Ag):该类抗原刺激机体时产生抗体时无需T细胞的辅助,又称T细胞非依赖性抗原。
10.异嗜性抗原(heterophile antigen):是一类与抗原种属性无关,存在于不同种属动物、植物、微生物之间的共同抗原。
11.超抗原(superantigen,SAg):只需要极低浓度(1~10ng/ml)即可激活2%~20%T细胞克隆,产生极强的免疫应答,这类抗原被称为超抗原。
(SAg不涉及TCR的识别,也不受MHC 分子的限制)12.佐剂(adjuvant):预先或与抗原同时注入体内,可增强机体对该抗原的免疫应答或改变免疫应答类型的非特异性免疫增强剂。
医学免疫学英文词汇
AAcquired immune deficiency syndrome, AIDS 获得性免疫缺陷综合征(艾滋病) Acquired immunity 获得性免疫Activation induced cell death,AICD 活化诱导的细胞死亡Active immunotherapy 主动免疫治疗Acute phase protein 急性时相蛋白Adapter 转接蛋白Adaptive immunity 适应性免疫Addressin 地址素Adenosine deaminase 腺苷脱氨酶Adjuvant 佐剂Adoptive immunity 过继免疫Adoptive immunotherapy,AIT 过继免疫治疗Affinity 亲和力Affinity maturation 亲和力成熟Agglutination 凝集反应Allelic exclusion 等位排斥Allergen 变应原Allergin 变应素Allergy 变态反应Allogenic antigen 同种异型抗原Allograft 同种异型移植Allotype 同种异型Allorecognition 同种异型识别Alpha-fetoprotein, AFP 甲种胎儿球蛋白Alternative pathway 旁路途径Anamnestic response 回忆应答Anaphylactic shock 过敏性休克Anaphylactogen 过敏原Anaphylaxis 过敏反应Anchor residue 锚定残基Ankylosing spondylitis,AS 强直性脊柱炎Antibacterial immune serum 抗菌免疫血清Antibody, Ab 抗体Antibody—dependent cell-mediated cytotoxicity, ADCC 抗体依赖性细胞介导的细胞毒作用Antiviral immune serum 抗病毒免疫血清Antigen,Ag 抗原Antigenic determinant 抗原决定簇Antigen internal image 抗原内影像Antigen—presenting cells,APC 抗原提呈细胞Antigen specific immune response 抗原特异性免疫应答Antigenicity 抗原性Anti-idiotype 抗独特型Antitoxic serum 抗毒素血清Apoptosis 细胞凋亡Apoptosis cell associated molecular pattern,ACAMP凋亡细胞相关的分子模式Apoptotic body 凋亡小体Artificial active immunization 人工主动免疫Artificial passive immunization 人工被动免疫Ataxia telangiectasia syndrome, AT 毛细血管扩张共济失调综合征Atopic dermatitisAutocrineAutograftAutoimmune antibodyAutoimmune disease,AIDAutoimmune hemolytic anemiaAutoimmune thrombocytopenic purpuraAutoimmunityBBacillus Calmette Guerin, BCGBare lymphocyte syndrome,BLSBasophilB cell epitope BB cell hybridoma BB cell linker ptotein,BLNKB cell receptor, BCRBiotin-avidin system, BASBispecific antibody, BsAbBlocking antibodyB lymphocyteBone marrowBone marrow transplantation, BMTBradykininCC1 inhibitor, C1 INHC4 binding protein,C8 binding protein, C8bpC—reactive protein,CRPCadherinCalcineurinCalmodulinCarcinoembryonic antigen,CEACarrierCecropinsCell adhesion molecules,CAM 特应性皮炎自分泌自体移植自身抗体自身免疫性疾病自身免疫性溶血性贫血自身免疫性血小板减少性紫癜自身免疫卡介苗裸淋巴细胞综合征嗜碱性粒细胞细胞表位细胞杂交瘤B 细胞连接蛋白B 细胞(抗原识别)受体生物素-亲和素系统双特异性抗体封闭抗体B淋巴细胞骨髓骨髓移植缓激肽C1抑制分子C4bp C4 结合蛋C8 结合蛋白C-反应蛋白钙粘蛋白钙神经素(钙调磷酸酶)钙调蛋白癌胚抗原载体杀菌肽细胞粘附分子hediak—Higashi syndrome Chediak-Higashi综合征Chemokine 趋化性细胞因子Chimeric antibody 嵌合抗体Chronic granulomatous disease,CGD 慢性肉芽肿病Class Ⅱtransactivator,C ⅡTA Ⅱ类反式活化子Class switch 类别转换Classical pathway 经典途径Clonal anergy 克隆无能Clonal deletion 克隆删除Clonal eliminationClonal expansionCluster of differentiation,CDColony stimulating factor,CSFCommon variable immunodeficiency ComplementComplement deficiencyComplement receptorComplementarity determining region,CDR Complete antigenConcanavalin A,Con A Conformational determinantConstant regionCo—receptorCo—stimulating signalCo-stimulatory molecules,CM Co—stimulatory molecule receptor,CMR Cross reactionCryptic determinantCytokine, CKCytolytic typeCytotoxic typeCytotoxic T lymphocytes,CTL 或Tc Cytotoxic T lymphocytes antigen—4, CTLA-4 DDecay accelerating factor,DAF DefensinsDelayed type hypersensitivity, DTH Delayed type hypersensitivity T cell, T DTH Dendritic cells, DCDiGeorge syndromeDiversity geneDNA vaccineDonorDouble immunodiffusion 克隆消除克隆扩增分化群集落刺激因子普通变化型免疫缺陷病补体补体缺陷补体受体互补性决定区完全抗原刀豆蛋白A 构象决定基恒定区,C区辅助受体协同刺激信号协同刺激分子协同刺激分子受体交叉反应隐蔽决定基细胞因子细胞溶解型细胞毒型细胞毒性T细胞细胞毒性T淋巴细胞(相关)抗原4 衰变加速因子防御素迟发型超敏反应迟发型超敏反应性T 细胞树突状细胞DiGeorge综合征D(多样化)基因DNA疫苗供者双向免疫扩散Double negative cell, DN cell 双阴性细胞Double positive cell, DP cell 双阳性细胞EE rosette test E 花结试验Early phase reaction 早期相反应Endocytosis 胞吞作用Enzyme immunoassay, EIA 酶免疫测定Enzyme linked immunosorbent assay, ELISA 酶联免疫吸附试验Eosinophil,Eos 嗜酸性粒细胞Eosinophil chemotactic factor,ECF 嗜酸性粒细胞趋化因子Eosinophil peroxidase, EPO 嗜酸性粒细胞过氧化物酶Epitope 表位Erythropoietin, EPO 红细胞生成素Extracellular matrix,ECM 细胞外基质F Fc receptor,FcR 结晶片断受体,Fc受体Flow cytometry, FCM 流式细胞术Fluorescence—activated cell sorter, FACS 荧光活化细胞分类器Follicular dendritic cells, FDC 滤泡树突状细胞Fragment antigen binding, Fab 抗原结合片断Fragment crystallizable,Fc 结晶片断Fragment of variable region Fv 片断Framework region 骨架区Freund complete adjuvant 弗氏完全佐剂GGenetic engineering antibody 基因工程抗体Germ line gene 胚系基因Germinal center 生发中心Glycosylphosphatidylinositol,GPI 糖磷脂酰肌醇Graft versus host reaction, GVHR 移植物抗宿主反应Granule exocytosis 颗粒胞吐Granulocyte colony stimulating factor, G-CSF 粒细胞集落刺激因子Granulocyte—macrophage colony stimulating factor,GM—CSF 粒细胞-巨噬细胞集落刺激因子Granzyme,Gz 颗粒酶Grave disease 毒性弥漫性甲状腺炎Growth factor 生长因子Growth factor receptor binding protein—2,Grb—2 生长因子受体结合蛋白2 Guanine nucleotide exchange factor, GEF 鸟苷酸置换因子Gut—associated lymphoid tissue,GALT 肠伴随(相关)淋巴组织H Haplotype 单元型Hapten 半抗原Hashimoto’s thyroiditis 桥本甲状腺炎Heat shock protein, HSP 热休克蛋白Heavy chain 重链,H 链Helper T cells(lymphocytes), Th 辅助性T 细胞Hemolytic plaque assay 溶血空斑试验Hemopoietic stem cell, HSC 造血干细胞Heterophil antigen 异嗜性抗原Hidden antigen 隐蔽抗原High endothelial venule,HEV 高内皮细胞小静脉Hinge region 铰链区Histamin 组胺Histocompatibility antigen—2, H-2HLA genotypingHomologous restriction factor, HRFHost versus graft reaction, HVGRHuman immunodeficiency virus,HIVHuman leukocyte antigen,HLAHumanized antibodyHumoral immunityHypersensitivityHypervariable region, HVRIIdiotype,IdIdiotype networkImmediate hypersensitivityImmune adherent,IAImmune complex,ICImmune function related geneImmune regulationImmune responseImmune response regionImmune serumImmune surveillanceImmune systemImmunityImmunocyteImmunodeficiency disease, IDDImmunofluorescenceImmunogenicityImmunoglobulin,IgImmunoglobulin superfamily, IgSFImmunohistochemistry techniqueImmunological competenceImmunological ignorance , ;Immunological toleranceImmunological non-responsiveness 小鼠的组织相容性抗原HLA 基因分型同源限制因子宿主抗移植物反应人类免疫缺陷病毒人类白细胞抗原人源化抗体体液免疫超敏反应高变独特型独特型网络速发型超敏反应免疫粘附免疫复合物免疫功能相关基因免疫调节免疫应答免疫应答区免疫血清免疫监视免疫系统免疫免疫细胞免疫缺陷病免疫荧光法免疫原性免疫球蛋白免疫球蛋白超家族免疫组化技术免疫适能免疫忽视免疫耐受免疫不应答Immunologically privileged sites 免疫隔离部位Immunology 免疫学Immunoreceptor tyrosine—based activation motifs, ITAM 免疫受体酪氨酸活化基序Immunoreceptor tyrosine—based inhibitory motifs, ITIM 免疫受体酪氨酸抑制基序Immunotherapy 免疫治疗Inactivated vaccine 灭活疫苗Inducible nitric oxide synthase, iNOS 诱导型一氧化氮合成酶Inflammatory cell 炎症细胞Innate immunity 固有(性)免疫Inositol-1, 4, 5-trisphosphate,IP3Insulin—dependent diabetes mellitus, IDDMIntercellular adhesion molecular,ICAMIntegrinInterferon,IFNInterleukin, ILInternalizationImtraepithelial lymphocytes, IELJJoining chainJoining geneKKiller activatory receptor,KARKiller inhibitory receptor, KIRKiller immunoglobulin like receptorKininogenaseLLangerhans cells, LCLarge granular lymphcytes,LGLsLate phase reactionLectinLectin—like carbohydrate recognition domain, CRDLeucine rich repeat, LRRLeukinLeukocyte adhesion deficiency, LADLeukocyte common antigen, LCALeukocyte differentiation antigen,LDALeukotrienes (Leucotrienes),LTsLigandLight chainLinker for activation of T cell,LATLinear determinantLinkage disequilibriumLipoteichoic acid,LTALipoxygenase pathway 三磷酸肌醇胰岛素依赖型糖尿病细胞间粘附分子整合素干扰素白细胞介素内化上皮细胞间淋巴细胞J链J 基因杀伤细胞活化受体杀伤细胞抑制受体杀伤细胞免疫球蛋白样受体激肽原酶郎格汉斯细胞大颗粒淋巴细胞晚期相反应凝集素凝集素样糖识别结构域富含亮氨酸的重复序列白细胞素白细胞粘附缺陷白细胞共同抗原白细胞分化抗原白三烯配基,配体轻链,L链T 细胞活化连接蛋白线性决定基连锁不平衡磷壁酸脂氧合酶途径Live—attenuated vaccine 减毒活疫苗Long—acting thyroid stimulator, LATS 长效甲状腺刺激素Low molecular—weight polypeptide, LMP 低分子量多肽LPS binding protein,LBP LPS结合蛋白Lymphocyte 淋巴细胞Lymphocyte function associated antigen,LFA 淋巴细胞功能相关抗原Lymphocyte homing 淋巴细胞归巢Lymphocyte homing receptor,LHR 淋巴细胞归巢受体Lymphoid DC 淋巴系树突状细胞Lymphoid progenitor 淋巴样祖细胞Lymphoid stem cells,LSC 淋巴样干细胞Lymphokine, LK 淋巴因子Lymphokine activated killer cell,LAK 淋巴因子激活的杀伤细胞Lymphotoxin,LT 淋巴毒素β —lysin 乙型溶素Lysosome-associated membrane proteins-1,LAMP—1 溶酶体相关膜蛋白1 Lysozyme 溶菌酶MMacrophages, M φ 巨噬细胞Macrophage colony stimulating factor,M—CSF 巨噬细胞集落刺激因子Macropinocytosis 巨吞饮Magainins 爪蟾抗菌肽Major histocompatibility complex,MHC 主要组织相容性复合体Mannan-binding lectin, MBL 甘露糖结合凝集素Mannose binding protein,MBP 甘露糖结合蛋白Mannose receptor, MR 甘露糖受体Mast cell,MC 肥大细胞MBL—associated serine protease,MASP MBL 伴随的丝氨酸蛋白酶Membrane attack complex,MAC 膜攻击复合物Membrane cofactor protein, MCP 膜辅助因子蛋白Membrane Ig, mIg 膜表面免疫球蛋白Membrane inhibitor of reactive lysis, MIRL 膜反应性溶解抑制物Memory cells 记忆细胞MHC class Ⅰgene MHC Ⅰ类基因MHC class Ⅱgene MHC Ⅱ类基因MHC class Ⅲgene MHC Ⅲ类基因MHC restriction MHC 限制性Microfold cell M细胞,微小褶皱细胞β 2-Microglobulin,β2—m β2 微球蛋白Minor histocompatibility antigen 次要组织相容性抗原Mitogen 丝裂原Mitogen-activation protein kinase, MAPK 丝裂原激活蛋白激酶M olecular mimicry 分子模拟Monoclonal antibody, McAb 单克隆抗体第7 / 11页Monocyte 单核细胞Monocyte chemotactic protein, MCP 单核细胞趋化蛋白Monokine, MK 单核因子Mononuclear—phagocyte system, MPS 单核—巨噬细胞系统Mucosal—associated lymphoid tissue,MALT 粘膜伴随(相关)淋巴组织Mucosal mast cell, MMC 粘膜肥大细胞Multiple hematopoietic stem cells,HSC 多能造血干细胞Multiple sclerosis,MS 多发性硬化症Myasthenia gravis,MG 重症肌无力Myeloid DCMyeloid stem cellMyeloperoxidase,MPONNaive T(B)cellsNatural cytotoxic cellNature killer cell,NK cellNeutrophilsNitric oxide, NONitroblue tetrazolium, NBTNon-classical MHC class ⅠgeneNon—organ specific autoimmune diseaseNon—specific immunityNude miceOOpsonizationOrgan specific autoimmune diseasePParacrineParoxysmal nocturnal hemoglobineria,PHNPassive immunotherapy ,Passive transfer of lymphocytePathogen associated molecular pattern,PAMPPattern recognition receptor, PRRPeptide antibioticsPeptidoglycan, PGNPerforinPeripheral lymphoid organPeyer's patchesPhagocytePhagocytosisPhagolysosomePhosphatidylinnosital pathway 髓系树突状细胞髓样干细胞髓过氧化物酶初始T(B)细胞自然细胞毒性细胞自然杀伤细胞嗜中性粒细胞一氧化氮氮蓝四唑非经典性Ⅰ类基因非器官特异性自身免疫病非特异性免疫裸小鼠,裸鼠调理作用器官特异性自身免疫病旁分泌夜间血红蛋白尿被动免疫治疗淋巴细胞被动转移病原相关分子模式模式识别受体肽抗菌肽聚糖穿孔素外周淋巴器官派氏集合淋巴结吞噬细胞吞噬作用吞噬溶酶体PI途径第8 / 11页Phosphatidylinositol-3—kinase, PI3-K 磷脂酰肌醇3激酶Phosphatidylinositol-4,5-bisphosphate,PIP 2 磷脂酰肌醇4,5二磷酸Phosphatidylinositol-3,4,5—trisphosphate 磷脂酰肌醇3,4,5三磷酸Phosphatidylserine, PS 磷脂酰丝氨酸Phosphoinositides 磷酸肌醇Phospholipase 磷脂酶Phospholipid bilineurine 磷脂胆碱Phosphotylinositide-3 kinase 磷酸肌醇—3激酶Phytohemagglutinin, PHA 植物血凝素PinocytosisPinocytotic vesiclePlacental γ globulinPlaque forming cell,PFCPlasma cellsPlatelet activating factor,PAFPolymeric Ig receptor, pIgRPolymorphismPolymorphic genesPolymorphonuclear neutrophils,PMNPrecipitationPrimary immunodeficiency disease,PIDDPrimary responsePro-B cellprofessional antigen presenting cellsProgrammed cell death,PCDProperdin, PProstaglandin,PGProtein kinase C,PKCProtein tyrosine kinase, PTKProtein tyrosine phosphatase,PTP/PTPaseProteolytic enzyme complexProteosomePurine nucleotide phosphorylase, PNPRγδ+T cellRadioimmunoassay,RIAReactive nitrogen intermediates,RNIsReactive oxygen intermediates,ROIsRearrangementReceptor editingReceptor—mediated endocytosisRecipientRecombinant antigen vaccineRecombinant vector vaccine 胞饮作用吞饮泡胎盘丙种球蛋白空斑形成细胞浆细胞血小板活化因子多聚免疫球蛋白受体多态性多态性基因多形核嗜中性粒细胞沉淀反应原发性免疫缺陷病初次应答祖B细胞专职抗原提呈细胞程序性细胞死亡备解素前列腺素蛋白激酶C 蛋白酪氨酸激酶蛋白酪氨酸磷酸酶蛋白水解酶复合体蛋白酶体嘌呤核苷磷酸化酶γδ+T细胞放射免疫测定法反应性氮中间物反应性氧中间物(基因)重排受体编辑受体介导的胞吞作用受者重组抗原疫苗重组载体疫苗第9 / 11页Recombinase 重组酶Recombination activating genes, RAG 重组活化基因Recombination signal sequences,RSS 重组信号序列Rejection (移植物的)排斥Rheumatoid arthritis, RA 类风湿性关节炎Rheumatoid factor, RF 类风湿因子SScavenger receptor, SR 清杂受体Secondary immunodeficiency disease,SIDD 继发性免疫缺陷病Secondary response 再次应答Secretory component, SC 分泌成分,分泌小体Secretory IgA,sIgA 分泌型免疫球蛋白ASecretory piece,SP 分泌片Selectin 选择素Selective IgA deficiency 选择性IgA缺陷Serin/threonine phosphatase 丝/苏氨酸磷酸酶Serum amyloid pretein A, SAA 血清淀粉样蛋白ASevere combined-immunodeficiency disease,SCID 重症联合免疫缺陷病Signal transduction 信号转导Signal transducers and activator of transcription, STAT 信号转导和活化转录因子Signalling complex 信号复合体Single immunodiffusion 单向免疫扩散Small G protein 小G 蛋白Sneaking through 漏逸Soluble TNF receptor,sTNFR 可溶性TNF受体Somatic hypermutation 体细胞高(频)突变Specific immunity 特异性免疫Split tolerance 耐受分离Src family kinase Src家族激酶Staphylococcus enterotoxin, SE 葡萄球菌肠毒素Staphylococcus protein A,SPA 葡萄球菌蛋白AStem cell factor,SCF 干细胞(生长)因子Subunit vaccine 亚单位疫苗Superantigen,SAg 超抗原Suppressor T cells, Ts 抑制性T细胞Syngraft 同种基因移植,同型移植Synthetic peptide vaccine 合成肽疫苗Systemic lupus erythematosus,SLE 系统性红斑狼疮TT cell epitope T细胞表位T cell receptor, TCR T细胞(抗原识别)受体T lymphocyte T淋巴细胞TCR/CD3 complex TCR/CD3 复合物Terminal deoxynucleotidyl transferase, TdT 末端脱氧核苷酸转移酶第10 / 11页Terminal pathway 末端通路Thrombopoietin 血小板生成素Thymic stromal cells,TSC 胸腺基质细胞Thymocyte 胸腺细胞Thymus 胸腺Thymus dependent antigen, TD-Ag 胸腺依赖抗原Thymus epithelial cells, TEC 胸腺上皮细胞Thymus independent antigen, TI—Ag 非胸腺依赖抗原Thyroid stimulating hormone, TSH 促甲状腺激素Tolerogen 耐受原Toll like receptor,TLR Toll样受体Toxoid &nbs, p;类毒素Transforming growth factor, TGF 转化生长因子Transporters associated with antigen processing,TAP 抗原处理相关转运蛋白Tumor-associated antigen, TAA 肿瘤相关抗原Tumor necrosis factor, TNF 肿瘤坏死因子Tumor—specific antigen,TSA 肿瘤特异性抗原VVariable folding 可变折叠Variable geng V基因Variable region (V region ) 可变区,V区Vitronectin 玻璃连接蛋白,玻连蛋白Very late appearing antigen,VLA 迟现抗原WWestern blotting 免疫印迹法Wiskott-Aldrich syndrome,WAS 伴湿疹血小板减少性免疫缺陷病XX-linked agammaglobulinemia,XLA 性联无丙种球蛋白血症X-li nked hyperimmunoglobulin M syndrome, HIM 性联高IgM综合征X-li nked SCID, XSCID 性联重症联合免疫缺陷病。
医学免疫学英文词汇
AAcquired immune deficiency syndrome, AIDS 获得性免疫缺陷综合征(艾滋病) Acquired immunity 获得性免疫Activation induced cell death, AICD 活化诱导的细胞死亡Active immunotherapy 主动免疫治疗Acute phase protein 急性时相蛋白Adapter 转接蛋白Adaptive immunity 适应性免疫Addressin 地址素Adenosine deaminase 腺苷脱氨酶Adjuvant 佐剂Adoptive immunity 过继免疫Adoptive immunotherapy, AIT 过继免疫治疗Affinity 亲和力Affinity maturation 亲和力成熟Agglutination 凝集反应Allelic exclusion 等位排斥Allergen 变应原Allergin 变应素Allergy 变态反应Allogenic antigen 同种异型抗原Allograft 同种异型移植Allotype 同种异型Allorecognition 同种异型识别Alpha-fetoprotein, AFP 甲种胎儿球蛋白Alternative pathway 旁路途径Anamnestic response 回忆应答Anaphylactic shock 过敏性休克Anaphylactogen 过敏原Anaphylaxis 过敏反应Anchor residue 锚定残基Ankylosing spondylitis, AS 强直性脊柱炎Antibacterial immune serum 抗菌免疫血清Antibody, Ab 抗体Antibody-dependent cell-mediated cytotoxicity, ADCC 抗体依赖性细胞介导的细胞毒作用Antiviral immune serum 抗病毒免疫血清Antigen, Ag 抗原Antigenic determinant 抗原决定簇Antigen internal image 抗原内影像Antigen-presenting cells, APC 抗原提呈细胞Antigen specific immune response 抗原特异性免疫应答Antigenicity 抗原性Anti-idiotype 抗独特型Antitoxic serum 抗毒素血清Apoptosis 细胞凋亡Apoptosis cell associated molecular pattern, ACAMP凋亡细胞相关的分子模式 Apoptotic body 凋亡小体Artificial active immunization 人工主动免疫Artificial passive immunization 人工被动免疫Ataxia telangiectasia syndrome, AT 毛细血管扩张共济失调综合征 Atopic dermatitisAutocrineAutograftAutoimmune antibodyAutoimmune disease, AIDAutoimmune hemolytic anemiaAutoimmune thrombocytopenic purpuraAutoimmunityBBacillus Calmette Guerin, BCGBare lymphocyte syndrome, BLSBasophilB cell epitope BB cell hybridoma BB cell linker ptotein, BLNKB cell receptor, BCRBiotin-avidin system, BASBispecific antibody, BsAbBlocking antibodyB lymphocyteBone marrowBone marrow transplantation, BMTBradykininCC1 inhibitor, C1 INHC4 binding protein,C8 binding protein, C8bpC-reactive protein,CRPCadherinCalcineurinCalmodulinCarcinoembryonic antigen, CEACarrierCecropinsCell adhesion molecules, CAM 特应性皮炎自分泌自体移植自身抗体自身免疫性疾病自身免疫性溶血性贫血自身免疫性血小板减少性紫癜自身免疫卡介苗裸淋巴细胞综合征嗜碱性粒细胞细胞表位细胞杂交瘤 B 细胞连接蛋白 B 细胞(抗原识别)受体生物素-亲和素系统双特异性抗体封闭抗体 B淋巴细胞骨髓骨髓移植缓激肽C1抑制分子 C4bp C4 结合蛋 C8 结合蛋白 C-反应蛋白钙粘蛋白钙神经素(钙调磷酸酶)钙调蛋白癌胚抗原载体杀菌肽细胞粘附分子hediak-Higashi syndrome Chediak-Higashi综合征 Chemokine 趋化性细胞因子 Chimeric antibody 嵌合抗体Chronic granulomatous disease, CGD 慢性肉芽肿病 Class Ⅱtransactivator, C Ⅱ TA Ⅱ类反式活化子 Class switch 类别转换Classical pathway 经典途径Clonal anergy 克隆无能Clonal deletion 克隆删除Clonal eliminationClonal expansionCluster of differentiation, CDColony stimulating factor, CSFCommon variable immunodeficiencyComplementComplement deficiencyComplement receptorComplementarity determining region, CDRComplete antigenConcanavalin A, Con AConformational determinantConstant regionCo-receptorCo-stimulating signalCo-stimulatory molecules, CMCo-stimulatory molecule receptor, CMR Cross reactionCryptic determinantCytokine, CKCytolytic typeCytotoxic typeCytotoxic T lymphocytes, CTL 或 Tc Cytotoxic T lymphocytes antigen-4, CTLA-4 DDecay accelerating factor, DAFDefensinsDelayed type hypersensitivity, DTHDelayed type hypersensitivity T cell, T DTH Dendritic cells, DCDiGeorge syndromeDiversity geneDNA vaccineDonorDouble immunodiffusion 克隆消除克隆扩增分化群集落刺激因子普通变化型免疫缺陷病补体补体缺陷补体受体互补性决定区完全抗原刀豆蛋白A 构象决定基恒定区,C区辅助受体协同刺激信号协同刺激分子协同刺激分子受体交叉反应隐蔽决定基细胞因子细胞溶解型细胞毒型细胞毒性T细胞细胞毒性T淋巴细胞(相关)抗原 4 衰变加速因子防御素迟发型超敏反应迟发型超敏反应性T细胞树突状细胞 DiGeorge综合征 D(多样化)基因 DNA疫苗供者双向免疫扩散Double negative cell, DN cell 双阴性细胞Double positive cell, DP cell 双阳性细胞EE rosette test E 花结试验Early phase reaction 早期相反应Endocytosis 胞吞作用Enzyme immunoassay, EIA 酶免疫测定Enzyme linked immunosorbent assay, ELISA 酶联免疫吸附试验Eosinophil, Eos 嗜酸性粒细胞Eosinophil chemotactic factor, ECF 嗜酸性粒细胞趋化因子Eosinophil peroxidase, EPO 嗜酸性粒细胞过氧化物酶 Epitope 表位Erythropoietin, EPO 红细胞生成素Extracellular matrix, ECM 细胞外基质F Fc receptor, FcR 结晶片断受体,Fc受体 Flow cytometry, FCM 流式细胞术Fluorescence-activated cell sorter, FACS 荧光活化细胞分类器 Follicular dendritic cells, FDC 滤泡树突状细胞 Fragment antigen binding, Fab 抗原结合片断Fragment crystallizable, Fc 结晶片断Fragment of variable region Fv 片断Framework region 骨架区Freund complete adjuvant 弗氏完全佐剂GGenetic engineering antibody 基因工程抗体Germ line gene 胚系基因Germinal center 生发中心Glycosylphosphatidylinositol, GPI 糖磷脂酰肌醇Graft versus host reaction, GVHR 移植物抗宿主反应 Granule exocytosis 颗粒胞吐Granulocyte colony stimulating factor, G-CSF 粒细胞集落刺激因子 Granulocyte-macrophage colony stimulating factor, GM-CSF 粒细胞-巨噬细胞集落刺激因子 Granzyme, Gz 颗粒酶Grave disease 毒性弥漫性甲状腺炎 Growth factor 生长因子Growth factor receptor binding protein-2,Grb-2 生长因子受体结合蛋白 2 Guanine nucleotide exchange factor, GEF 鸟苷酸置换因子Gut-associated lymphoid tissue, GALT 肠伴随(相关)淋巴组织 HHaplotype 单元型Hapten 半抗原Hashimoto’s thyroiditis 桥本甲状腺炎Heat shock protein, HSP 热休克蛋白Heavy chain 重链,H 链Helper T cells(lymphocytes), Th 辅助性 T 细胞 Hemolytic plaque assay 溶血空斑试验 Hemopoietic stem cell, HSC 造血干细胞 Heterophil antigen 异嗜性抗原 Hidden antigen 隐蔽抗原High endothelial venule, HEV 高内皮细胞小静脉 Hinge region 铰链区Histamin 组胺Histocompatibility antigen-2, H-2HLA genotypingHomologous restriction factor, HRFHost versus graft reaction, HVGRHuman immunodeficiency virus, HIVHuman leukocyte antigen,HLAHumanized antibodyHumoral immunity Hypersensitivity Hypervariable region, HVRIIdiotype, IdIdiotype networkImmediate hypersensitivity Immune adherent, IAImmune complex, ICImmune function related gene Immune regulationImmune responseImmune response region Immune serumImmune surveillanceImmune systemImmunityImmunocyteImmunodeficiency disease, IDD Immunofluorescence ImmunogenicityImmunoglobulin, IgImmunoglobulin superfamily, IgSFImmunohistochemistry techniqueImmunological competenceImmunological ignorance , ;Immunological toleranceImmunological non-responsiveness 小鼠的组织相容性抗原HLA 基因分型同源限制因子宿主抗移植物反应人类免疫缺陷病毒人类白细胞抗原人源化抗体体液免疫超敏反应高变独特型独特型网络速发型超敏反应免疫粘附免疫复合物免疫功能相关基因免疫调节免疫应答免疫应答区免疫血清免疫监视免疫系统免疫免疫细胞免疫缺陷病免疫荧光法免疫原性免疫球蛋白免疫球蛋白超家族免疫组化技术免疫适能免疫忽视免疫耐受免疫不应答Immunologically privileged sites 免疫隔离部位Immunology 免疫学Immunoreceptor tyrosine-based activation motifs, ITAM 免疫受体酪氨酸活化基序 Immunoreceptor tyrosine-based inhibitory motifs, ITIM 免疫受体酪氨酸抑制基序 Immunotherapy 免疫治疗Inactivated vaccine 灭活疫苗Inducible nitric oxide synthase, iNOS 诱导型一氧化氮合成酶Inflammatory cell 炎症细胞Innate immunity 固有(性)免疫Inositol-1, 4, 5-trisphosphate,IP3Insulin-dependent diabetes mellitus, IDDM Intercellular adhesion molecular,ICAMIntegrinInterferon, IFNInterleukin, ILInternalizationImtraepithelial lymphocytes, IELJJoining chainJoining geneKKiller activatory receptor, KARKiller inhibitory receptor, KIRKiller immunoglobulin like receptor KininogenaseLLangerhans cells, LCLarge granular lymphcytes, LGLsLate phase reactionLectinLectin-like carbohydrate recognition domain, CRDLeucine rich repeat, LRRLeukinLeukocyte adhesion deficiency, LADLeukocyte common antigen, LCALeukocyte differentiation antigen, LDALeukotrienes (Leucotrienes), LTsLigandLight chainLinker for activation of T cell, LATLinear determinantLinkage disequilibriumLipoteichoic acid, LTALipoxygenase pathway 三磷酸肌醇胰岛素依赖型糖尿病细胞间粘附分子整合素干扰素白细胞介素内化上皮细胞间淋巴细胞 J链J基因杀伤细胞活化受体杀伤细胞抑制受体杀伤细胞免疫球蛋白样受体激肽原酶郎格汉斯细胞大颗粒淋巴细胞晚期相反应凝集素凝集素样糖识别结构域富含亮氨酸的重复序列白细胞素白细胞粘附缺陷白细胞共同抗原白细胞分化抗原白三烯配基,配体轻链,L 链 T细胞活化连接蛋白线性决定基连锁不平衡磷壁酸脂氧合酶途径Live-attenuated vaccine 减毒活疫苗Long-acting thyroid stimulator, LATS 长效甲状腺刺激素Low molecular-weight polypeptide, LMP 低分子量多肽LPS binding protein, LBP LPS结合蛋白Lymphocyte 淋巴细胞Lymphocyte function associated antigen, LFA 淋巴细胞功能相关抗原 Lymphocyte homing 淋巴细胞归巢Lymphocyte homing receptor, LHR 淋巴细胞归巢受体Lymphoid DC 淋巴系树突状细胞Lymphoid progenitor 淋巴样祖细胞Lymphoid stem cells, LSC 淋巴样干细胞Lymphokine, LK 淋巴因子Lymphokine activated killer cell, LAK 淋巴因子激活的杀伤细胞 Lymphotoxin, LT 淋巴毒素β -lysin 乙型溶素Lysosome-associated membrane proteins-1,LAMP-1 溶酶体相关膜蛋白1 Lysozyme 溶菌酶MMacrophages, M φ巨噬细胞Macrophage colony stimulating factor, M-CSF 巨噬细胞集落刺激因子 Macropinocytosis 巨吞饮Magainins 爪蟾抗菌肽Major histocompatibility complex, MHC 主要组织相容性复合体 Mannan-binding lectin, MBL 甘露糖结合凝集素Mannose binding protein, MBP 甘露糖结合蛋白Mannose receptor, MR 甘露糖受体Mast cell, MC 肥大细胞MBL-associated serine protease, MASP MBL 伴随的丝氨酸蛋白酶 Membrane attack complex, MAC 膜攻击复合物Membrane cofactor protein, MCP 膜辅助因子蛋白Membrane Ig, mIg 膜表面免疫球蛋白Membrane inhibitor of reactive lysis, MIRL 膜反应性溶解抑制物 Memory cells 记忆细胞MHC class Ⅰ gene MHC Ⅰ类基因MHC class Ⅱ gene MHC Ⅱ类基因MHC class Ⅲ gene MHC Ⅲ类基因MHC restriction MHC 限制性Microfold cell M细胞,微小褶皱细胞β 2-Microglobulin, β2 -m β2 微球蛋白Minor histocompatibility antigen 次要组织相容性抗原 Mitog en 丝裂原Mitogen-activation protein kinase, MAPK 丝裂原激活蛋白激酶 Molecular mimicry 分子模拟Monoclonal antibody, McAb 单克隆抗体第7 / 11页Monocyte 单核细胞Monocyte chemotactic protein, MCP 单核细胞趋化蛋白Monokine, MK 单核因子Mononuclear-phagocyte system, MPS 单核-巨噬细胞系统Mucosal-associated lymphoid tissue, MALT 粘膜伴随(相关)淋巴组织 Mucosal mast cell, MMC 粘膜肥大细胞Multiple hematopoietic stem cells, HSC 多能造血干细胞Multiple sclerosis, MS 多发性硬化症Myasthenia gravis, MG 重症肌无力Myeloid DCMyeloid stem cellMyeloperoxidase, MPONNaive T(B) cellsNatural cytotoxic cellNature killer cell, NK cellNeutrophilsNitric oxide, NONitroblue tetrazolium, NBTNon-classical MHC class Ⅰ geneNon-organ specific autoimmune diseaseNon-specific immunityNude miceOOpsonizationOrgan specific autoimmune diseasePParacrineParoxysmal nocturnal hemoglobineria, PHNPassive immunotherapy ,Passive transfer of lymphocytePathogen associated molecular pattern, PAMPPattern recognition receptor, PRRPeptide antibioticsPeptidoglycan, PGNPerforinPeripheral lymphoid organPeyer’s patchesPhagocytePhagocytosisPhagolysosomePhosphatidylinnosital pathway 髓系树突状细胞髓样干细胞髓过氧化物酶初始T(B)细胞自然细胞毒性细胞自然杀伤细胞嗜中性粒细胞一氧化氮氮蓝四唑非经典性Ⅰ类基因非器官特异性自身免疫病非特异性免疫裸小鼠,裸鼠调理作用器官特异性自身免疫病旁分泌夜间血红蛋白尿被动免疫治疗淋巴细胞被动转移病原相关分子模式模式识别受体肽抗菌肽聚糖穿孔素外周淋巴器官派氏集合淋巴结吞噬细胞吞噬作用吞噬溶酶体 PI途径第8 / 11页Phosphatidylinositol-3-kinase, PI3-K 磷脂酰肌醇3激酶Phosphatidylinositol-4,5-bisphosphate, PIP 2 磷脂酰肌醇4,5二磷酸 Phosphatidylinositol-3,4,5-trisphosphate 磷脂酰肌醇3,4,5三磷酸 Phosphatidylserine, PS 磷脂酰丝氨酸Phosphoinositides 磷酸肌醇Phospholipase 磷脂酶Phospholipid bilineurine 磷脂胆碱Phosphotylinositide-3 kinase 磷酸肌醇-3激酶Phytohemagglutinin, PHA 植物血凝素PinocytosisPinocytotic vesiclePlacental γ globulinPlaque forming cell, PFCPlasma cellsPlatelet activating factor, PAFPolymeric Ig receptor, pIgRPolymorphismPolymorphic genesPolymorphonuclear neutrophils, PMN PrecipitationPrimary immunodeficiency disease, PIDD Primary responsePro-B cellprofessional antigen presenting cells Programmed cell death, PCDProperdin, PProstaglandin, PGProtein kinase C, PKCProtein tyrosine kinase, PTKProtein tyrosine phosphatase, PTP/PTPase Proteolytic enzyme complexProteosomePurine nucleotide phosphorylase, PNPRγδ+T cellRadioimmunoassay, RIAReactive nitrogen intermediates, RNIs Reactive oxygen intermediates, ROIs RearrangementReceptor editingReceptor-mediated endocytosisRecipientRecombinant antigen vaccineRecombinant vector vaccine 胞饮作用吞饮泡胎盘丙种球蛋白空斑形成细胞浆细胞血小板活化因子多聚免疫球蛋白受体多态性多态性基因多形核嗜中性粒细胞沉淀反应原发性免疫缺陷病初次应答祖B细胞专职抗原提呈细胞程序性细胞死亡备解素前列腺素蛋白激酶C 蛋白酪氨酸激酶蛋白酪氨酸磷酸酶蛋白水解酶复合体蛋白酶体嘌呤核苷磷酸化酶γδ+T细胞放射免疫测定法反应性氮中间物反应性氧中间物(基因)重排受体编辑受体介导的胞吞作用受者重组抗原疫苗重组载体疫苗第9 / 11页Recombinase 重组酶Recombination activating genes, RAG 重组活化基因Recombination signal sequences, RSS 重组信号序列Rejection (移植物的)排斥Rheumatoid arthritis, RA 类风湿性关节炎Rheumatoid factor, RF 类风湿因子SScavenger receptor, SR 清杂受体Secondary immunodeficiency disease, SIDD 继发性免疫缺陷病Secondary response 再次应答Secretory component, SC 分泌成分,分泌小体Secretory IgA, sIgA 分泌型免疫球蛋白 ASecretory piece, SP 分泌片Selectin 选择素Selective IgA deficiency 选择性IgA缺陷Serin/threonine phosphatase 丝/苏氨酸磷酸酶Serum amyloid pretein A, SAA 血清淀粉样蛋白 ASevere combined-immunodeficiency disease, SCID 重症联合免疫缺陷病 Signal transduction 信号转导Signal transducers and activator of transcription, STAT 信号转导和活化转录因子 Signalling complex 信号复合体Single immunodiffusion 单向免疫扩散Small G protein 小 G 蛋白Sneaking through 漏逸Soluble TNF receptor, sTNFR 可溶性TNF受体Somatic hypermutation 体细胞高(频)突变Specific immunity 特异性免疫Split tolerance 耐受分离Src family kinase Src家族激酶Staphylococcus enterotoxin, SE 葡萄球菌肠毒素Staphylococcus protein A, SPA 葡萄球菌蛋白 AStem cell factor, SCF 干细胞(生长)因子Subunit vaccine 亚单位疫苗Superantigen, SAg 超抗原Suppressor T cells, Ts 抑制性T细胞Syngraft 同种基因移植,同型移植 Synthetic peptide vaccine 合成肽疫苗Systemic lupus erythematosus, SLE 系统性红斑狼疮TT cell epitope T细胞表位T cell receptor, TCR T细胞(抗原识别)受体 T lymphocyte T 淋巴细胞TCR/CD3 complex TCR/CD3 复合物Terminal deoxynucleotidyl transferase, TdT 末端脱氧核苷酸转移酶第10 / 11页Terminal pathway 末端通路Thrombopoietin 血小板生成素Thymic stromal cells, TSC 胸腺基质细胞Thymocyte 胸腺细胞Thymus 胸腺Thymus dependent antigen, TD-Ag 胸腺依赖抗原Thymus epithelial cells, TEC 胸腺上皮细胞Thymus independent antigen, TI-Ag 非胸腺依赖抗原Thyroid stimulating hormone, TSH 促甲状腺激素Tolerogen 耐受原Toll like receptor, TLR Toll样受体Toxoid &nbs, p; 类毒素Transforming growth factor, TGF 转化生长因子Transporters associated with antigen processing,TAP 抗原处理相关转运蛋白 Tumor-associated antigen, TAA 肿瘤相关抗原Tumor necrosis factor, TNF 肿瘤坏死因子Tumor-specific antigen, TSA 肿瘤特异性抗原VVariable folding 可变折叠Variable geng V基因Variable region ( V region ) 可变区,V区Vitronectin 玻璃连接蛋白,玻连蛋白 Very late appearing ant igen, VLA 迟现抗原WWestern blotting 免疫印迹法Wiskott-Aldrich syndrome, WAS 伴湿疹血小板减少性免疫缺陷病 XX-linked agammaglobulinemia, XLA 性联无丙种球蛋白血症 X-l inked hyperimmunoglobulin M syndrome, HIM 性联高IgM综合征 X-l inked SCID, XSCID 性联重症联合免疫缺陷病。
免疫学名词解释(同名7065)
免疫学名词解释1、免疫〔Immunity〕:免疫是指机体识别和去除一切抗原异物以保持自身稳定的生理反响,如果免疫系统失调,免疫反响过强、过弱或对自身成分发生免疫应答都将对机体造成损害。
2、免疫防御〔immunologic defense〕:免疫防御指防止外界病原体入侵和去除已入侵病原体及有害的生物性分子,此功能就是机体的抗感染免疫。
但异常情况下,免疫反响过强可引起超敏反响,而免疫功能过低那么表现为易受感染或免疫缺陷病等。
3、免疫自稳:〔immune homeostasis〕:免疫自稳指机体对自身成分的耐受,对自身衰老和损伤细胞的去除,阻止外来异物入侵并通过免疫调节到达维持机体内环境稳定的功能。
4、免疫监视〔immunologic surveillance〕:免疫监视是指监督机体内环境出现的突变细胞及早期肿瘤,并予以去除。
假设此功能失调,体内突变细胞失控,可导致肿瘤发生,假设病毒感染不能及时被去除,而出现病毒持续性感染状态。
5、淋巴细胞归巢(lymphocyte homing ):成熟淋巴细胞离开中枢淋巴器官后,经血液循环趋向性迁移并定居在外周淋巴器官或组织的特定区域,称为淋巴细胞归巢。
6、淋巴细胞再循环(lymphocyte recirculation):定居在外周淋巴器官的淋巴细胞,可由输出淋巴管经淋巴干、胸导管或右淋巴导管进入血液循环,淋巴细胞随血液循环到达外周免疫器官后,可穿越HEV,并重新分布于全身淋巴器官和组织。
淋巴细胞在血液、淋巴液、淋巴器官或组织间反复循环的过程称为淋巴细胞再循环。
7、抗原〔Antigen,Ag〕:是一类能刺激机体免疫系统产生特异性免疫应答,并能与相应的免疫应答产物在体内或体外发生特异性结合的物质。
免疫原性(Immunogenicity):是指抗原能刺激特定的免疫细胞〔克隆〕,使之活化、增殖、分化,产生免疫效应物质(抗体和致敏淋巴细胞)的特性.免疫反响性(Immunoreactivity);也称抗原性(Antigenicity):是指抗原与相应的免疫效应物质(抗体或/和致敏淋巴细胞〕,在体内体外发生特异性结合的特性.8、半抗原〔hapten〕:仅有免疫反响性而无免疫原性的物质。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
Virus Research 142(2009)169–174Contents lists available at ScienceDirectVirusResearchj o u r n a l h o m e p a g e :w w w.e l s e v i e r.c o m /l o c a t e /v i r u s r esAntigenic differentiation of classical swine fever viruses in China by monoclonal antibodiesYan Zhu a ,Zixue Shi a ,Trevor W.Drew b ,Qin Wang c ,Huaji Qiu d ,Huanchen Guo a ,Changchun Tu a ,∗aInstitute of Veterinary Sciences,Academy of Military Medical Sciences,1068Qinglong Road,Changchun 130062,China b Veterinary Laboratories Agency,Weybridge,Surrey KT153NB,UK cChina Institute of Veterinary Drug Control,Beijing 100081,China dDivision of Swine Infectious Diseases,National Key Laboratory of Veterinary Biotechnology,Harbin Veterinary Research Institute,Chinese Academy of Agricultural Sciences,Harbin 150001,Chinaa r t i c l e i n f o Article history:Received 25November 2008Received in revised form 12February 2009Accepted 13February 2009Available online 26February 2009Keywords:CSFV mAbsAntigenic differentiationa b s t r a c tThe phylogenetic diversity of classical swine fever virus (CSFV)in China has been extensively studied previously,with the report of the classification of Chinese CSFVs into four subgroups within two of the established genotypes,but the antigenic differences amongst Chinese CSF viruses still remain unknown.To address this issue,21CSFV field strains isolated in China between 1996and 2006were grown in cell culture and characterized in comparison with two Chinese reference strains:a virulent strain Shimen and a vaccine strain CSF lapinized virus (hog cholera lapinized virus in China,HCLV),by indirect immunoflu-orescence assay (IFA)with a panel of 28monoclonal antibodies (mAbs)against four pestiviruses,CSFV,bovine viral diarrhoea virus-1(BVDV-1),bovine viral diarrhoea virus-2(BVDV-2)and border disease virus (BDV).All 23CSFV strains reacted only with CSFV-specific mAbs,not with those raised against BVDV-1,BVDV-2and BDV.Of the former mAbs,those directed against CSFV E2protein recognized more isolates than those directed against E rns and NS2/3.Of nine CSFV E2-specific mAbs used,WH303and WH302reacted with all 23strains,confirming their value in differentiating CSFV from other pestiviruses.Fur-thermore,different strains had different patterns of reactivity with CSFV-specific mAbs,and mAbs other than WH303and WH302did not recognize all strains.This study provides the first evidence for the existence of antigenic differences among Chinese CSFVs.©2009Elsevier B.V.All rights reserved.1.IntroductionClassical swine fever (CSF)is a highly contagious febrile dis-ease of domestic and wild pigs (Moennig,2000).Outbreaks can cause heavy losses to the swine industry and hamper international trade of animals and animal products;hence,it is notifiable to the World Organisation for Animal Health (OIE,2006)and to the Euro-pean Union (Anon.,1982).The etiological agent,CSFV,is a small enveloped virus with a positive,single-stranded RNA genome.This pathogen,together with BVDV-1,BVDV-2and BDV,form the genus Pestivirus of the family Flaviviridae (Heinz et al.,2004).These four viruses are both structurally and antigenically related (Terpstra,1978;Westaway et al.,1985).Serum antibodies induced by infec-tion with one species usually cross-react with antibodies induced by other members within the same genus,thereby making the dif-ferentiation of one species from another by polyclonal antibodies very difficult (Darbyshire,1960;Wensvoort et al.,1989a,b ).This∗Corresponding author.Tel.:+8643187960009;fax:+8643187960009.E-mail address:changchun tu@ (C.Tu).characteristic also makes a clear identification of serotypes of CSFVs impossible.The diversity of CSFV can be demonstrated by phylogenetic anal-ysis and monoclonal antibody analysis,two important approaches in understanding the epidemiology of CSF.Phylogenetic analysis is a particularly valuable tool for revealing genetic interrelations and tracing the likely epidemiological origins of a particular virus fol-lowing an outbreak.In the last decade,the genetic diversity of CSFV has been extensively studied by this method,resulting in the classi-fication of CSFVs into 3major groups and 10subgroups (Paton et al.,2000).The accurate antigenic analysis of viruses has traditionally involved the use of panels of mAbs,which is a sensitive and valuable method for demonstrating the degree of antigenic diversity among viruses.Serologically,CSFV is considered monotypic,generally dis-playing only small differences within the species.From the time when mAbs against pestiviruses were first described in 1986(Peters et al.,1986;Wensvoort et al.,1986),mAb-associated antigenic dif-ferentiation has been the primary means by which CSFV isolates from different parts of the world have been antigenically character-ized (Edwards and Sands,1990;Kosmidou et al.,1995;Nishimori et al.,1996;Mendoza et al.,2007).At a more fundamental level,this0168-1702/$–see front matter ©2009Elsevier B.V.All rights reserved.doi:10.1016/j.virusres.2009.02.011170Y.Zhu et al./Virus Research142(2009)169–174technique has also been used to differentiate CSFV from other pes-tiviruses(Wensvoort,1989;Zhou et al.,1989;Nishimori et al.,1996). Edwards et al.(1991)developed a panel of30mAbs as part of a study to demonstrate the differing reactivity patterns among pestiviruses, which could be used to differentiatedfield CSFV isolates,both from vaccine strains and from other pestiviruses.This work resulted in the technique becoming a standard method for confirmatory diag-nosis of CSF.Another panel of mAbs,developed by Nishimori et al. (1996),could classify20CSF viruses into6antigenic types.Our previous phylogenetic study of isolates of CSFV revealed4 genetic subgroups(1.1,2.1,2.2and2.3)prevalent in China(Tu et al.,2001),but the antigenic diversity among Chinese CSFV isolates remained unknown.In this study we describe thefirst characteri-zation offield CSFV strains isolated in China,using an established panel of mAbs against pestiviruses.2.Materials and methods2.1.Viral strains,clinical specimens and mAbsThe Chinese virulent CSFV reference strain Shimen and currently used vaccine strain HCLV were obtained from China Institute of Veterinary Drug Control.Field strains of CSFV were obtained by iso-lation from spleens and kidneys of clinically suspect CSF pigs and were randomly dependent on their availability during outbreaks. The specimens collected between1996and1999,from10differ-ent provinces of China,were described in the previous study(Tu et al.,2001).The specimens collected between2005and2006in this study were from four provinces,three of which were different from the previous study,making a total representation of thirteen provinces throughout the country(Table1).The specimens were first subjected to RT-PCR gene amplification,followed by sequenc-ing based on procedures previously published(Tu et al.,2001). All positive tissue specimens were then subjected to virus isola-tion.The mAbs used in this study were culture supernatants of hybridoma cells,which were prepared and provided by the Vet-erinary Laboratories Agency,Weybridge,UK.2.2.Viral isolationTen-fold diluted suspensions of suspected CSF tissues were added to porcine kidney(PK-15)cell monolayers and incubated at 37◦C for72h in Minimum Essential Medium(MEM)supplementedTable1Chinesefield CSFV strains.Strain Provincial origin Year Genotype Accession No.GD6(96)Guangdong1996 2.2FJ157195GD16(98)Guangdong1998 2.3FJ157193GZ1(99)Guizhou1999 2.1FJ157198GZ2(99)Guizhou1999 1.1FJ157199 HaN1(99)Hainan1999 2.3FJ157200 HeN1(98)Henan1998 2.1FJ157204 HeN10(06)Henan2006 2.1FJ157205 HeN11(06)Henan2006 2.1FJ157206 HeN12(06)Henan2006 2.1FJ157207 HeN13(06)Henan2006 2.1FJ157208 HuN5(05)Hunan2005 2.1FJ157209 HLJ4(06)Heilongjiang2006 2.1FJ157210HLJ5(06)Heilongjiang2006 2.1FJ157211JL15(06)Jilin2006 2.1FJ157212JL16(06)Jilin2006 1.1FJ157213LN2(99)Liaoning1999 2.1FJ157201 NMG7(99)Inner Mongolia1999 2.2FJ157202NX2(99)Ningxia1999 2.1FJ157203SD1(98)Shandong1998 2.2FJ157194YN4(96)Yunnan1996 2.1FJ157196ZJ2(99)Zhejiang1999 2.2FJ157197with10%new-born calf serum(NBCS)known to be free of BVDV virus and antibody(Hyclone,Logan,UT,USA).Three consecutive blind passages were performed for each specimen supernatant. Successful isolations were confirmed at the third passage by RT-PCR and IFA using pig anti-CSFV hyperimmune serum(prepared in our laboratory)and FITC-conjugated rabbit anti-pig IgG(Sigma,St. Louis,MO,USA).2.3.Antigenic differentiation by mAb staining and indirectimmunofluorescence assay(IFA)Ninety-six well microtitre plates(Costar,NY,USA)were seeded with PK-15cells in MEM+10%NBCS and cultivated at37◦C in5% CO2overnight to70–80%confluence.The cultures were then inoc-ulated with20-fold dilutedfield CSFV isolates at passage3,with rows left uninfected,to act as negative controls,and incubated at 37◦C in a5%CO2atmosphere.Each plate was infected with only one strain.The virulent strain Shimen(100TCID50/well)was cultured in PK-15cells in a similar fashion,while the HCLV was cultured in primary newborn(1–3days old)calf testicle cells since HCLV is not porcine cell line-adapted.After72h,the plates werefixed in80% cold acetone in PBS,then washed and incubated with mAbs at a 50-fold dilution.To ensure accuracy in antigenic differentiation,all mAbs were applied simultaneously to one plate,with two replicate infected wells(experimental)and one uninfected well(negative control)for each mAb.Following washes with PBS,FITC-conjugated goat anti-mouse IgG(Sigma,St.Louis,MO,USA)was added to the plates,followed by a1-h incubation in a37◦C humid box.After 3washes with PBS,50%glycerol in PBS was added to each well. Two infected wells were similarly treated,but using pig anti-CSFV hyperimmune serum and a porcine FITC conjugate,as a positive control to confirm viral growth.Fluorescence was observed using an Axioskop-40fluorescence inverted microscope(Zeiss,Germany).2.4.Phylogenetic analysisSequence comparisons and phylogenetic analyses of all iso-lated viruses and reference strains were based on190bp of the E2gene,using the methodology and,for specimens col-lected between1996and1999,the data,as published previously (Tu et al.,2001).The phylogenetic analyses were conducted using the neighbour-joining algorithm of MEGA software version 3.1(/)and the maximum parsi-mony method of PHYLIP software version 3.63(Seattle,WA, USA).The tree was estimated statistically by1000replicates of the bootstrap value and visualized by the TREEVIEW program (/rod/treeview.html).3.Results and discussion3.1.Virus isolationIn our study,63clinically suspect CSF isolates showed positive amplification of CSFV E2gene in RT-PCR,but only21of them per-mitted successful viral isolation,resulting in a harvest of21field strains representing13provinces and spanning the decade from 1996to2006(see Table1).About two-thirds of specimens failed viral isolation,possibly because the long storage at−20◦C would have greatly decreased the amount of viable virus and therefore the likelihood of isolation.In addition,many specimens had been freeze–thawed more than three times.After isolation,eachfield strain at passage3grew successfully in PK-15cells,with extensive staining by IFA using pig anti-CSFV hyperimmune serum,as well as a strong signal in RT-PCR.Therefore,the third passages offield strains in cell cultures were used for antigenic differentiation.172Y.Zhu et al./Virus Research142(2009)169–1743.2.Antigenic differentiationIn the present study,we have shown the antigenic differentia-tion of Chinese CSFVs by using28mAbs respectively against BVDV, BDV and CSFV.All21Chinesefield CSFV strains from13provinces, as well as two reference strains,were recognized by CSFV-specific mAbs but not by mAbs specific to ruminant pestiviruses(4mAbs against BVDV-1,3mAbs against BVDV-2and2mAbs against BDV: see footnote in Table2.).Table2reveals antigenic differentiation of Chinese CSFVs and summarizes their reactive patterns with19 CSFV-specific mAbs.In the positive reactions,each CSFV strain showed different levels of intensity of staining with different mAbs,which could be divided into strong(+++),moderate(++)and weak(+)reactions based on the intensity of immunofluorescence staining.Among these CSFV-specific mAbs,anti-E rns mAbs WH178and WH179detected no strains and mAbs WH174,WH180and WH 186detected only one strain.The other14mAbs reacted varyingly, providing unique reaction patterns with all23CSFV strains,indi-cating antigenic variation among the epitopes that they recognize. The anti-E2mAbs recognized more CSFV strains than the anti-E rns and anti-NS2/3mAbs.Glycoprotein E2is the major immunogenic protein of CSFV with antigenic epitopes located in four distinct anti-genic domains on E2protein(Wensvoort,1989).Of the9anti-E2 mAbs,WH303and WH302recognized all23strains,indicating that their epitopes on the E2protein are highly conserved and present in all CSFV strains.This confirms the conclusion of Edwards et al. (1991)that these two mAbs are valuable for specific and sensitive confirmation of pestivirus isolates as CSFV.A study by Lin et al. (2000)showed that the epitope recognized by mAb WH303isCSFV-Fig.1.Phylogenetic analysis of21Chinesefield strains with reference strains by comparison of190bp of the E2gene,using the methodology published previously(Tu et al.,2001).Twenty-five reference sequences were retrieved from GenBank and are:Shimen(U72047),HCLV(U72048),Alfort(J04358),Breseia(M31768),C1W(L36164),C2W (L36165),C3D(L36166),C4D(L36167),C6W(L36168),N5W(L36169),S7D2(L36171),S7D(L36170),S8D(L36172),ALD(D49532),GPE-(D49533),CAP(X96550),Weybridge (X71780),Riems(U45477),KoreaYI990(AF521710),Korea96940(AF521711),Korea88039(DQ656345),JJ9811(AF521708),TWN/93(AY571088),Taiwan(U03290),RBR88 (AF241618).Y.Zhu et al./Virus Research142(2009)169–174173specific and mapped to829–837aa of E2protein(TAVSPTTLR).This epitope is highly conserved and has not shown any genetic variation in the comparison of all CSFV E2sequences of group1and2viruses available to date from GenBank(data not shown).This epitope of WH303is a key antigenic site,since it is a determinant not only for neutralization(Liu et al.,2006),but it has also been shown that engineered changes of this site alter virulence(Risatti et al.,2006). Interestingly a CSF genotype3.3virus,Thai strain CBR/93(Sakoda et al.,1999)did not efficiently bind WH303and has the antigenic motif TAVSSTTLER,rather than TAVSPTTLER at that binding site and this isolate exhibits a somewhat different disease presentation(Everett et al.,submitted for publication).Thisfinding indicates that fur-ther study is warranted to explore the sequence diversity of the WH303epitope among genotype3viruses which are present in some countries in Asia(Sakoda et al.,1999).Anti-E2mAbs WH187,WH310,WH306and WH211detected 69.5–86.9%of strains,indicating that their epitopes are present in most Chinese CSFV strains.In contrast,the epitopes recognized by the remaining three anti-E2mAbs(WH220,WH308and WH304) may be rare or absent from the majority of Chinese strains.This is in contrast to past studies using these mAbs,where the majority of CSFV isolates were recognised(Edwards and Sands,1990).The anti-E rns mAbs and anti-NS2/3mAb detected a quite few field strains which reacted with only one or two anti-E rns mAbs. Of the anti-E rns mAbs,WH217recognized six strains.Interestingly, the reference strains Shimen and HCLV reacted with a broader spec-trum of anti-E rns mAbs,showing a unique antigenic type which may have potential use in differentiation fromfield viruses.Nishimori et al.(1996)reported that the application of20mAbs raised against CSFV virulent strain ALD or vaccine strain GPE—could classify20 Japanese CSFVs into6antigenic types and discriminate between vaccine strains andfield isolates.Edwards and Sands,1990used19CSFV-specific mAbs in a peroxidase-linked immune binding assay to determine the reac-tion patterns of CSFV isolates from Europe,Brazil,USA,Japan and Malaysia.Six of these mAbs reacted with all CSFV isolates,while the rest13recognized some isolates with a link between geographical location and reactivity pattern.In the present study,however,the21field strains were isolated from specimens collected between1996 and2006from13provinces and the antigenic differentiation did not show geographical reactivity patterns as observed by Edwards and Sands,1990.This probably reflects the endemic nature of the disease in China and the regular movements of pigs and pig meat that occur between provinces.3.3.Phylogenetic typing and mAb typingThere is only one serotype of CSFV but three major genetic groups do exist(Edwards et al.,1991;Paton et al.,2000).In order to assess the correlation between mAb typing and genetic typing, a phylogenetic analysis of the21field strains was performed,also comparing them with reference strains representing3major groups (Paton et al.,2000).Results showed that allfield CSFVs could be classified within four subgroups(subgroups1.1,2.1,2.2,and2.3: see Fig.1),which represent current genotypes circulating in China (Tu et al.,2001).No group3viruses were found.We found that some field strains placed distantly in mAb typing(Table2),although they grouped closely by genotype(e.g.,GZ-2/99and JL-16/06in sub-group1.1,GD16/98and HaN1/99in subgroup2.3,GD6/96,ZJ2/99 and SD1/98in subgroup2.2,HeN1/98and JL15/06in subgroup 2.1;see Fig.1).In contrast,JL-16/06and YN-4/96had the same mAb spectrum recognizing them,but belong to different genetic groups.While some isolates of the same genotype showed the same mAb spectrum(e.g.,HLJ4/06,HLJ5/06,HeN11/06,HeN12/06 and HeN13/06were grouped subgroup2.1and had the same mAb reactivity pattern),the diversity of reactivity among the isolates,taken as a whole,lead us to conclude that there is no correlation between mAb typing and genetic typing.Therefore these two meth-ods should be considered as two independent approaches to the analysis of CSFV diversity.In the published literature,a relatively small number offield CSFVs have been characterized antigenetically using different pan-els of mAbs.It is difficult to compare these studies,because a panel of well-defined standard mAbs was not used.In contrast, genetic typing can allow a standardised approach,using the same regions on the viral genome to compare CSFVs isolated in differ-ent geographic regions or countries,also with the ability to trace the putative origin of isolates by their degree of genetic similarity. Nowadays,field CSFVs are usually subjected to genetic typing upon their detection in outbreaks and hundreds of CSFVs have been phy-logenetically analyzed,resulting in a global view of CSFV diversity. We conclude that monoclonal antibody typing is an ideal method to study the antigenic diversity among CSFV isolates within a country or region,but genetic typing is more suitable forfield epidemiology studies,and therefore more widely used.AcknowledgementsThis work was supported by the following grants to CT:two Chinese National Scientific and Technological Supporting Programs (Nos.2006BAD06A03and2006BAD06A18),and the National973 Program(No.2005CB523200).TD was funded by the UK govern-ment in his OIE role,under Defra Project SV3000.ReferencesAnon.,1982.Council Directive82/894/EEC of21December1982on the notification of animal diseases within the Community.Official Journal L378,0058-62. Darbyshire,J.H.,1960.A serological relationship between swine fever and mucosal disease of cattle.Vet.Rec.72,331.Edwards,S.,Sands,J.J.,1990.Antigenic comparisons of hog cholera virus isolates from Europe.America and Asia using monoclonal antibodies.Dtsch.Tierärztl.Wochenschr.97,79–81.Edwards,S.,Moening,V.,Wensvoort,G.,1991.The development of an international reference panel of monoclonal antibodies for the differentiation of hog cholera virus from other pestiviruses.Vet.Microbiol.29,101–108.Everett,H.,Salguero,F.J.,Graham,S.P.,Haines,F.,Johns,H.,Clifford,D.,Nunez, Rocca,A.,Parchariyanon,S.,Steinbach,F.,Drew,T.,Crooke,H.Characterisation of experimental infections of domestic pigs with genotype2.1and3.3isolates of classical swine fever virus.Vet.Microbiol.(submitted for publication). Heinz,F.X.,Collett,M.S.,Purcell,Gould,R.H.,Howard,E.A.,Houghton,C.R.,Moor-mann,R.J.M.,Rice,C.M.,Thiel,H.-J.,2004.Family Flaviridae.In:Fauquet,C.M., Mayo,M.,Maniloff,J.,Desselberger,U.,Ball,L.A.(Eds.),Virus Taxonomy.Eighth Report of the International Committee on Taxonomy of Virus.Academic Press, San Diego,pp.981–998.Kosmidou,A.,Ahl,R.,Thiel,H.J.,Weiland,E.,1995.Differentiation of classical swine fever virus(CSFV)strains using monoclonal antibodies against structural glyco-proteins.Vet.Microbiol.47,111–118.Lin,M.,Lin,F.,Mallory,M.,Alfonso,C.,2000.Deletions of structural glycoprotein E2of classical swine fever virus strain Alfort/187resolve a lineal epitope of monoclonal antibody WH303and the minimal N terminal domain essential for binding immunoglobulin G antibodies of a pig hyperimmune serum.J.Virol.74, 11619–11625.Liu,S.,Tu,C.,Wang,C.,Yu,X.,Wu,W.,Guo,S.,Shao,M.,Gong,Q.,Zhu,Q.,Kong, X.,2006.The protective immune response induced by B cell epitope of classical swine fever virus glycoprotein E2.J.Virol.Methods134,125–129.Mendoza,S.,Correa-Giron,P.,Aguilera,E.,Colmenares,G.,Torres,O.,Cruz,T.,Romero,A.,Hernandez-Baumgarten,E.,Ciprian,A.,2007.Antigenic differentiation ofclassical swine fever vaccinal strain PAV-250from other strains,includingfield strains from Mexico.Vaccine25,7120–7124.Moennig,V.,2000.Introduction to classical swine fever virus,disease and control policy.Vet.Microbiol.73,93–102.Nishimori,T.,Yamada,S.,Shimizu,M.,1996.Production of monoclonal antibod-ies against classical swine fever and their use for antigenic characterization of Japanese isolates.J.Vet.Med.Sci.58,707–710.OIE,2006.Diseases notifiable to the OIE.http://www.oie.int/eng/maladies/ en classification/htm.Paton,J.,McGoldrick,A.,Greiser-Wilke,I.,Parchariyanon,S.,Song,J.Y.,Liou,P.P., Stadejek,T.,Lowing,J.P.,Bjorklund,H.,Belak,S.,2000.Genetic typing of classical swine fever virus.Vet.Microbiol.73,137–157.Peters,W.,Greiser-Wilke,I.,Moennig,V.,Liess,B.,1986.Preliminary serological char-acterization of bovine viral diarrhea virus strains using monoclonal antibodies.Vet.Microbiol.12,195–200.174Y.Zhu et al./Virus Research142(2009)169–174Risatti,G.R.,Holinka,L.G.,Carrillo,C.,Kutish,G.F.,Lu,Z.,Tulman,E.R.,Sainz,I.F., Borca,M.V.,2006.Identification of a novel virulence determinant within the E2structural glycoprotein of classical swine fever virus.Virology355(1), 94–101.Sakoda,Y.,Ozawa,S.,Damrongwatanapokin,S.,Sato,M.,Ishikawa,K.,Fukusho,A., 1999.Genetic heterogeneity of porcine and ruminant pestiviruses mainly iso-lated in Japan.Vet.Microbiol.65(1),75–86.Terpstra, C.,1978.Detection of border disease antigen in tissues of affected sheep and in cell cultures by immunofluorescence.Res.Vet.Sci.25,350–355.Tu,C.,Lu,Z.,Li,H.,Yu,X.,Liu,X.,Li,Y.,Zhang,H.,Yin,Z.,2001.Phylogenetic comparison of classical swine fever virus in China.Virus Res.81,29–37.Wensvoort,G.,1989.Topographical and functional mapping of epitopes of hog cholera virus with monoclonal antibodies.J.Gen.Virol.70,2865–2876.Wensvoort,G.,Terpstra,C.,Boonstra,J.,Bloemraad,M.,van Zaane,D.,1986.Pro-duction of monoclonal antibodies against swine fever virus and their use in laboratory diagnosis.Vet.Microbiol.12,101–108.Wensvoort,G.,Terpstra,C.,de Kluijver,E.P.,Kragten,C.,Warnaar,J.C.,1989a.Anti-genic differentiation of pestivirus strains with monoclonal antibodies against hog cholera virus.Vet.Microbiol.21,9–20.Wensvoort,G.,Terpstra,C.,de Kluyver,E.P.,1989b.Characterization of porcine and some ruminant pestiviruses by cross-neutralization.Vet.Microbiol.20,291–306. Westaway,E.G.,Brinton,M.A.,Gaidamovich,S.Ya.,Horzinek,M.C.,Igarashu,A.,Kaari-ainen,L.,Lvov,D.K.,Porterfield,J.S.,Russell,P.K.,Trent,D.W.,1985.Togaviridae.Intervirology24,125–139.Zhou,Y.,Moening,V.,Coulibaly,D.,Dahle,J.,Liess,B.,1989.Differentiation of hog cholera and bovine virus diarrhoea viruses in pigs using monoclonal antibodies.Zentralbl.Vet.36,76–80.。